97 results on '"Letachowicz K"'
Search Results
2. Prevalence of Left Ventricular Hypertrophy and Left Ventricular Dysfunction in Older Renal Transplant Recipients
- Author
-
Letachowicz, K., Boratyńska, M., Obremska, M., Kamińska, D., Goździk, A., Mazanowska, O., and Klinger, M.
- Published
- 2016
- Full Text
- View/download PDF
3. A randomized multicenter trial on a lung ultrasound-guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk see commentary
- Author
-
Zoccali, C., Torino, C., Mallamaci, F., Sarafidis, P., Papagianni, A., Ekart, R., Hojs, R., Klinger, M., Letachowicz, K., Fliser, D., Seiler-Mussler, S., Lizzi, F., Wiecek, A., Miskiewicz, A., Siamopoulos, K., Balafa, O., Slotki, I., Shavit, L., Stavroulopoulos, A., Covic, A., Siriopol, D., Massy, Z.A., Seidowsky, A., Battaglia, Y., Martinez-Castelao, A., Polo-Torcal, C., Coudert-Krier, M.J., Rossignol, P., Fiaccadori, E., Regolisti, G., Hannedouche, T., Bachelet, T., Jager, K.J., Dekker, F.W., Tripepi, R., Tripepi, G., Gargani, L., Sicari, R., Picano, E., and London, G.M.
- Subjects
cardiovascular risk ,lung congestion ,heart failure hemodialysis ,chronic kidney failure ,ESRD ,lung ultrasound - Abstract
Lung congestion is a risk factor for all-cause and cardiovascular mortality in patients on chronic hemodialysis, and its estimation by ultrasound may be useful to guide ultrafiltration and drug therapy in this population. In an international, multi-center randomized controlled trial (NCT02310061) we investigated whether a lung ultrasound-guided treatment strategy improved a composite end point (all-cause death, non-fatal myocardial infarction, decompensated heart failure) vs usual care in patients receiving chronic hemodialysis with high cardiovascular risk. Patient-Reported Outcomes (Depression and the Standard Form 36 Quality of Life Questionnaire, SF36) were assessed as secondary outcomes. A total of 367 patients were enrolled: 183 in the active arm and 180 in the control arm. In the active arm, the pre-dialysis lung scan was used to titrate ultrafiltration during dialysis and drug treatment. Three hundred and seven patients completed the study: 152 in the active arm and 155 in the control arm. During a mean follow-up of 1.49 years, lung congestion was significantly more frequently relieved in the active (78%) than in the control (56%) arm and the intervention was safe. The primary composite end point did not significantly differ between the two study arms (Hazard Ratio 0.88; 95% Confidence Interval: 0.63-1.24). The risk for all-cause and cardiovascular hospitalization and the changes of left ventricular mass and function did not differ among the two groups. A post hoc analysis for recurrent episodes of decompensated heart failure (0.37; 0.15-0.93) and cardiovascular events (0.63; 0.41-0.97) showed a risk reduction for these outcomes in the active arm. There were no differences in patientreported outcomes between groups. Thus, in patients on chronic hemodialysis with high cardiovascular risk, a treatment strategy guided by lung ultrasound effectively relieved lung congestion but was not more effective than usual care in improving the primary or secondary end points of the trial.
- Published
- 2021
- Full Text
- View/download PDF
4. Effective treatment of Kaposi sarcoma with everolimus in a patient with membranous glomerulonephritis
- Author
-
Rukasz, D., Krajewska, M., Augustyniak-Bartosik, H., Letachowicz, K., Hałoń, A., Ekiert, M., Jakuszko, K., Madziarska, K., Weyde, W., and Klinger, M.
- Published
- 2015
- Full Text
- View/download PDF
5. DIALYSIS VASCULAR ACCESS
- Author
-
Fontsere, N., primary, Mestres, G., additional, Burrel, M., additional, Barrufet, M., additional, Montana, X., additional, Arias, M., additional, Ojeda, R., additional, Maduell, F., additional, Campistol, J. M., additional, Nagaraja, P., additional, Rees, D., additional, Husein, T., additional, Chess, J., additional, Lin, C.-C., additional, Yang, W.-C., additional, Khosravi, M., additional, Kandil, H., additional, Cross, J., additional, Hopkins, S., additional, Collier, S., additional, Lopes, D., additional, Pereira, S., additional, Gomes, A. M., additional, Ventura, A., additional, Martins, V., additional, Seabra, J., additional, Rothuizen, T. C., additional, Damanik, F., additional, Visser, M. J. T., additional, Lavrijsen, T., additional, Cox, M. A. J., additional, Moroni, L., additional, Rabelink, T. J., additional, Rotmans, J. I., additional, Fontsere, N., additional, Cardozo, C., additional, Donate, J., additional, Soriano, A., additional, Muros, M., additional, Pons, M., additional, Mensa, J., additional, Navarro-Gonzalez, J. F., additional, Wijewardane, A., additional, Murley, A., additional, Powers, S., additional, Allen, C., additional, Baharani, J., additional, Wilmink, T., additional, Esenturk, M., additional, Zengin, M., additional, Dal, M., additional, Tahtal , N., additional, Shibata, K., additional, Shinzato, T., additional, Satta, H., additional, Nishihara, M., additional, Koguchi, N., additional, Kuji, T., additional, Kawata, S., additional, Kaneda, T., additional, Yasuda, G., additional, Scrivano, J., additional, Pettorini, L., additional, Rutigliano, T., additional, Ciavarella, G. M., additional, De Biase, L., additional, Punzo, G., additional, Mene, P., additional, Pirozzi, N., additional, El Haggan, W., additional, Belazrague, K., additional, Ehoussou, S., additional, Foucher, V., additional, El Salhy, M., additional, Ouellet, G., additional, Davis, J., additional, Caron, P., additional, Leblanc, M., additional, Romitelli, F., additional, Fazzari, L., additional, Ortu, G., additional, Di Stasio, E., additional, Loizzo, G., additional, Vigano, S. M., additional, Bacchini, G., additional, Rocchi, E., additional, Sala, V., additional, Pontoriero, G., additional, Letachowicz, K., additional, Go biowski, T., additional, Kusztal, M., additional, Letachowicz, W., additional, Weyde, W., additional, Klinger, M., additional, Hollingsworth, L., additional, Roca-Tey, R., additional, Samon, R., additional, Ibrik, O., additional, Roda, A., additional, Gonzalez-Oliva, J. C., additional, Martinez-Cercos, R., additional, Viladoms, J., additional, Renaud, C. J., additional, Lim, E. K., additional, Seow, T. Y., additional, Teh, H. S., additional, Tosic, J., additional, Jankovic, A., additional, Djuric, P., additional, Radovic Maslarevic, V., additional, Popovic, J., additional, Dimkovic, N., additional, Kazantzi, A., additional, Trigka, K., additional, Buono, F., additional, Laurino, S., additional, Toriello, G., additional, Di Luccio, R., additional, Galise, A., additional, Kim, Y. O., additional, Yoon, S. A., additional, Kim, Y. S., additional, Choi, S. J., additional, Min, J. W., additional, Cheong, M. A., additional, Asano, M., additional, Oguchi, K., additional, Saito, A., additional, Onishi, Y., additional, Yamamoto, Y., additional, Fukuhara, S., additional, Akiba, T., additional, Akizawa, T., additional, Kurokawa, K., additional, Guedes Marques, M., additional, Ibeas, J., additional, Maia, P., additional, Ponce, P., additional, Chang, K. Y., additional, Park, H. S., additional, Kim, H. W., additional, Choi, B. S., additional, Park, C. W., additional, Yang, C. W., additional, Jin, D. C., additional, Likaj, E., additional, Seferi, S., additional, Caco, G., additional, Petrela, E., additional, Barbullushi, M., additional, Idrizi, A., additional, Thereska, N., additional, Lomonte, C., additional, Casucci, F., additional, Libutti, P., additional, Lisi, P., additional, Basile, C., additional, Ancarani, P., additional, Valsuani, G., additional, Cavallo, L., additional, Parodi, D., additional, Lorusso, C., additional, Renaud, C., additional, Lai, B. C., additional, Tho, S., additional, Yeoh, L., additional, Botelho, C., additional, Yankovoy, A., additional, Alexandr, S., additional, Smoliacov, A., additional, Stepanov, V., additional, Parker, C., additional, Davies, P., additional, Taylor, S., additional, Mikhail, A., additional, Gubensek, J., additional, Persic, V., additional, Vajdic, B., additional, Ponikvar, R., additional, Buturovic-Ponikvar, J., additional, Hadimeri, U., additional, Warme, A. V., additional, Stegmayr, B., additional, Suvakov, S., additional, Damjanovic, T., additional, Bajcetic, S., additional, Radovic-Maslarevic, V., additional, Simic, T., additional, Rroji, M., additional, Chua, H. L., additional, Kanda, H., additional, See, S. L., additional, Liew, N. C., additional, Tsuchida, K., additional, Tomo, T., additional, Fukasawa, M., additional, Kawashima, S., additional, Minakuchi, J., additional, Thanaraj, V., additional, Dhaygude, A., additional, Ikeda, K., additional, Forneris, G., additional, Cecere, P., additional, Pozzato, M., additional, Trogolo, M., additional, Vallero, A., additional, Mesiano, P., additional, Roccatello, D., additional, Keskin, L., additional, Casey, J. R., additional, Hanson, C. S., additional, Winkelmayer, W. C., additional, Craig, J., additional, Palmer, S., additional, Strippoli, G., additional, Tong, A., additional, Ferrara, D., additional, Scamarda, S., additional, Bernardino, L., additional, Amico, L., additional, Lorito, M. C., additional, Incalcaterra, f., additional, Visconti, L., additional, Visconti, G., additional, Valenza, F., additional, D'Amato, F., additional, Di Napoli, A., additional, Tazza, L., additional, Chicca, S., additional, Lapucci, E., additional, Silvestri, P., additional, Di Lallo, D., additional, Michelozzi, P., additional, and Davoli, M., additional
- Published
- 2014
- Full Text
- View/download PDF
6. HAEMODIALYSIS TECHNIQUES AND ADEQUACY 2
- Author
-
Chamney, P., primary, Moissl, U., additional, Wabel, P., additional, Amato, C., additional, Stuard, S., additional, Menzer, M., additional, Vollmeier, C., additional, Williams, G., additional, Shrivastava, R., additional, Chess, J., additional, Catling, E., additional, Brown, C., additional, Baker, E., additional, Ashcroft, R., additional, Mikhail, A., additional, Djukanovic, L., additional, Djuric, Z., additional, Knezevic, V., additional, Lazarevic, T., additional, Ljubenovic, S., additional, Markovic, R., additional, Rabrenovic, V., additional, Marinkovic, J., additional, Dimkovic, N., additional, Lebourg, L., additional, Ridel, C., additional, De Preneuf, H., additional, Le Roy, F., additional, Petitclerc, T., additional, Wester, M., additional, Simonis, F., additional, Kooman, J. P., additional, Boer, W. H., additional, Gerritsen, K. G. F., additional, Joles, J. A., additional, Yamamoto, K.-i., additional, Eguchi, K., additional, Hirakawa, S., additional, Murakami, J., additional, Akiba, T., additional, Mineshima, M., additional, Stamopoulos, D., additional, Mpakirtzi, N., additional, Lavranos, A., additional, Panagiotou, M., additional, Barbarousi, D., additional, Matsouka, C., additional, Grapsa, E., additional, Abbas, S. R., additional, Zhu, F., additional, Kaysen, G. A., additional, Kotanko, P., additional, Levin, N. W., additional, Vasilevsky, A., additional, Konoplev, G., additional, Stepanova, O., additional, Rubinsky, A., additional, Zemchenkov, A., additional, Gerasimchuk, R., additional, Frorip, A., additional, Abe, T., additional, Yamamoto, K.-I., additional, Ishimori, I., additional, Kusztal, M., additional, Go Biowski,, T., additional, Letachowicz, K., additional, Koni Ski, P., additional, Witkowski, G., additional, Pozna Ski, P., additional, Weyde, W., additional, Klinger, M., additional, Ito, M., additional, Ito, S., additional, Suzuki, M., additional, Masakane, I., additional, Navarro, D., additional, Goncalves, C., additional, Ferreira, A. C., additional, Jorge, C., additional, Gil, C., additional, Aires, I., additional, Matias, P., additional, Mendes, M., additional, Azevedo, A., additional, Gomes, F., additional, Ferreira, A., additional, Perazzini, C., additional, Scutiero, L., additional, Brighenti, L., additional, Surace, A., additional, Steckiph, D., additional, Rovatti, P., additional, Severi, S., additional, Soltysiak, J., additional, Warzywoda, A., additional, Musielak, A., additional, Ostalska-Nowicka, D., additional, Zachwieja, J., additional, Goeksel, T., additional, Garnier, H., additional, Ritzerfeld, M., additional, Mann, H., additional, Babinet, F., additional, Allard, B., additional, Todorova, V., additional, Hamont, C., additional, Begri, R., additional, Dekker, M., additional, Taks, M., additional, Konings, C., additional, Scharnhorst, V., additional, Borawski, J., additional, Gozdzikiewicz-Lapinska, J., additional, Naumnik, B., additional, Lodi, C. A., additional, Grandi, E., additional, Mancini, E., additional, Santoro, A., additional, Sereni, L., additional, Caiazzo, M., additional, Corazza, L., additional, Atti, M., additional, Palladino, G., additional, Sakurai, K., additional, Saito, T., additional, Hosoya, H., additional, Yamauchi, F., additional, Kurihara, T., additional, Tanibayashi, Y., additional, Ikebe, N., additional, Antonic, M., additional, Gubensek, J., additional, Drozg, A., additional, Vannier, E., additional, Mattio, E., additional, Ragon, A., additional, Brunet, P., additional, Klimm, W., additional, Pleskacz, K., additional, Pietrzak, B., additional, Niemczyk, S., additional, Leypoldt, J. K., additional, Bernardo, A., additional, Muller, M., additional, Marbury, T. C., additional, Culleton, B. F., additional, Zeraati, A. A., additional, Hekmat, R., additional, Reyhani, H. R., additional, Sharifipoor, F., additional, Bolasco, P., additional, Sitzia, I., additional, Monni, A., additional, Mereu, M. C., additional, Pinna, A. M., additional, Logias, F., additional, Ghisu, T., additional, Passaghe, M., additional, Gazzanelli, L., additional, Ganadu, M., additional, Piras, A., additional, Cossu, M., additional, Contu, B., additional, Palleschi, S., additional, Rossi, B., additional, Ghezzi, P. M., additional, Kron, S., additional, Schneditz, D., additional, Leimbach, T., additional, Aign, S., additional, Kron, J., additional, Seker Kockara, A., additional, Kayatas, M., additional, Huzmeli, C., additional, Candan, F., additional, Yilmaz, M. B., additional, Ahmed, B. A., additional, Bejosano, C. N., additional, Samra Abouchacra, S. A., additional, Al Falahi, S. Z., additional, Abdul Moniem, K. M., additional, Dastoor, H., additional, Kim, S., additional, Oh, J., additional, Sin, Y., additional, Kim, J., additional, and Lee, J., additional
- Published
- 2014
- Full Text
- View/download PDF
7. Vascular access
- Author
-
Coentrao, L., primary, Ribeiro, C., additional, Santos-Araujo, C., additional, Neto, R., additional, Pestana, M., additional, Rahman, E., additional, Rahman, H., additional, Ahmed, D., additional, Mousa, D., additional, El Bishlawi, M., additional, Shibahara, H., additional, Shibahara, N., additional, Takahashi, S., additional, Dupuis, E., additional, Duval, X., additional, Dornic, Q., additional, Bonnal, C., additional, Lucet, J.-C., additional, Cerceau, O., additional, Randoux, C., additional, Balde, C., additional, Besson, F., additional, Mentre, F., additional, Vrtovsnik, F., additional, Koutroubas, G., additional, Malindretos, P., additional, Zagotsis, G., additional, Makri, P., additional, Syrganis, C., additional, Mambelli, E., additional, Mancini, E., additional, Elia, C., additional, Guadagno, V., additional, Facchini, M. G., additional, Zucchelli, A., additional, Grazia, M., additional, Patregnani, L., additional, Santoro, A., additional, Stefan, G., additional, Stancu, S., additional, Capusa, C., additional, Ailioaiei, O. R., additional, Mircescu, G., additional, Anwar, S., additional, Little, C., additional, Kingston, R., additional, Diwakar, P., additional, Kaikini, R., additional, Nikolaou, E., additional, Loukas, G., additional, Sabry, A., additional, Alsaran, K., additional, Al Sherbeiny, S., additional, Abdulkader, M., additional, Kwak, I., additional, Song, S., additional, Seong, E., additional, Lee, S., additional, Lee, D., additional, Kim, I., additional, Rhee, H., additional, Silva, F., additional, Queiros, J., additional, Malheiro, J., additional, Cabrita, A., additional, Rocha, A., additional, Bamidis, P., additional, Liaskos, C., additional, Chryssogonidis, I., additional, Frantzidis, C., additional, Papagiannis, A., additional, Vrochides, D., additional, Lasaridis, A., additional, Nikolaidis, P., additional, Kotwal, S., additional, Muir, C., additional, Hawley, C., additional, Snelling, P., additional, Gallagher, M., additional, Jardine, M., additional, Shibata, K., additional, Toya, Y., additional, Umemura, S., additional, Iwamoto, T., additional, Ono, S., additional, Ikeda, E., additional, Kitazawa, A., additional, Kuji, T., additional, Koguchi, N., additional, Satta, H., additional, Nishihara, M., additional, Kawata, S., additional, Kaneda, T., additional, Yamada, Y., additional, Murakami, T., additional, Yanagi, M., additional, Yasuda, G., additional, Mathieu, S., additional, Yves, D., additional, Jean-Michel, T., additional, Nicolas, Q., additional, Jean-Francois, C., additional, Ibrahim, M., additional, Abdel Salam, M., additional, Awadalla, A., additional, Bichari, W., additional, Zaki, S., additional, Roca-Tey, R., additional, Samon, R., additional, Ibrik, O., additional, Roda, A., additional, Gonzalez-Oliva, J. C., additional, Martinez-Cercos, R., additional, Viladoms, J., additional, Lin, C.-C., additional, Yang, W.-C., additional, Kim, Y.-O., additional, Yoon, S.-A., additional, Yun, Y.-S., additional, Song, H.-C., additional, Kim, B.-S., additional, Cheong, M.-A., additional, Ogawa, T., additional, Kiba, T., additional, Okazaki, S., additional, Hatano, M., additional, Iwanaga, M., additional, Noiri, C., additional, Matsuda, A., additional, Hasegawa, H., additional, Mitarai, T., additional, DI Napoli, A., additional, DI Lallo, D., additional, Tazza, L., additional, De Cicco, C., additional, Salvatori, M. F., additional, Chicca, S., additional, Guasticchi, G., additional, Gelev, S., additional, Trajceska, L., additional, Srbinovska, E., additional, Pavleska, S., additional, Oncevski, A., additional, Dejanov, P., additional, Gerasomovska, V., additional, Selim, G., additional, Sikole, A., additional, Wilson, S., additional, Mayne, T., additional, Krishnan, M., additional, Holland, J., additional, Volz, A., additional, Good, L., additional, Nissenson, A., additional, Stavroulopoulos, A., additional, Aresti, V., additional, Maragkakis, G., additional, Kyriakides, S., additional, Rikker, C., additional, Juhasz, E., additional, Tornoci, L., additional, Tovarosi, S., additional, Greguschik, J., additional, Mag, O., additional, Rosivall, L., additional, Golebiowski, T., additional, Watorek, E., additional, Kusztal, M., additional, Letachowicz, K., additional, Letachowicz, W., additional, Madziarska, K., additional, Augustyniak Bartosik, H., additional, Krajewska, M., additional, Weyde, W., additional, Klinger, M., additional, Capitanini, A., additional, Lange, S., additional, Cupisti, A., additional, Schier, T., additional, Gobel, G., additional, Bosmuller, C., additional, Gruber, I., additional, Tiefenthaler, M., additional, Shipley, T., additional, Adam, J., additional, Sweeney, D., additional, Fenwick, S., additional, Mansy, H., additional, Ahmed, S., additional, Moore, I., additional, Vigeral, P., additional, Saksi, S., additional, Flamant, M., additional, Boulanger, H., additional, Park, W.-D., additional, Cheong, M. A., additional, Nikam, M., additional, Tavakoli, A., additional, Chemla, E., additional, Evans, J., additional, Malete, H., additional, Matyas, L., additional, Mogan, I., additional, Lazarides, M., additional, Ebner, A., additional, Shi, Y., additional, Zhang, J., additional, Cheng, J., additional, Frank, L. R., additional, Melanie, H., additional, Dominique, B., additional, Michel, G., additional, Ikeda, K., additional, Yasuda, T., additional, Yotueda, H., additional, Ebah, L., additional, Jayanti, A., additional, Kanigicherla, D., additional, Summers, A., additional, Manley, G., additional, Dutton, G., additional, Chalmers, N., additional, Mitra, S., additional, Checherita, I.-A., additional, Niculae, A., additional, Radulescu, D., additional, David, C., additional, Turcu, F. L., additional, Ciocalteu, A., additional, Persic, V., additional, Buturovic-Ponikvar, J., additional, Ponikvar, R., additional, Touam, M., additional, Menoyo, V., additional, Drueke, T., additional, Rifaat, M., additional, Muresan, C., additional, Abtahi, M., additional, Koochakipour, Z., additional, Joly, D., additional, Baharani, J., additional, Rizvi, S., additional, Ng, K. P., additional, Buzzi, L., additional, Sarcina, C., additional, Alberghini, E., additional, Ferrario, F., additional, Baragetti, I., additional, Santagostino, G., additional, Furiani, S., additional, Corghi, E., additional, Terraneo, V., additional, Rastelli, F., additional, Bacchini, G., additional, Pozzi, C., additional, Adorati Menegato, M., additional, Mortellaro, R., additional, Locicero, A., additional, Romano, A., additional, Manzini, P. P., additional, Steckiph, D., additional, Shintaku, S., additional, Kawanishi, H., additional, Moriishi, M., additional, Bansyodani, M., additional, Nakamura, S., additional, Saito, M., additional, Tsuchiya, S., additional, Barros, F., additional, Vaz, R., additional, Carvalho, B., additional, Martins, P., additional, Likaj, E., additional, Seferi, S., additional, Rroji, M., additional, Idrizi, A., additional, Duraku, A., additional, Barbullushi, M., additional, and Thereska, N., additional
- Published
- 2012
- Full Text
- View/download PDF
8. Native forearm fistulas utilizing the basilic vein: An underused type of vascular access
- Author
-
Weyde W, Letachowicz W, Magdalena Krajewska, Letachowicz K, Watorek E, Kusztal M, Porazko T, Gołebiowski T, Madziarska K, and Klinger M
9. Routine use of the transradial approach in primary percutaneous coronary intervention.
- Author
-
Letachowicz K, Letachowicz W, Kusztal M, Weyde W, and Klinger M
- Published
- 2012
10. THE ULNAR-BASILIC FISTULA.
- Author
-
Weyde, W., Letachowicz, W., Krajewska, M., Letachowicz, K., Kusztal, M., Golebiowski, T., Madziarska, K., and Klinger, M.
- Published
- 2010
11. Machine learning validation of the AVAS classification compared to ultrasound mapping in a multicentre study.
- Author
-
Lawrie K, Waldauf P, Balaz P, Bortel R, Lacerda R, Aitken E, Letachowicz K, D'Oria M, Di Maso V, Stasko P, Gomes A, Fontainhas J, Pekar M, Srdelic A, and O'Neill S
- Subjects
- Humans, Female, Male, Middle Aged, Prospective Studies, Aged, Arteriovenous Shunt, Surgical, ROC Curve, Bayes Theorem, Machine Learning, Ultrasonography methods
- Abstract
The Arteriovenous Access Stage (AVAS) classification simplifies information about suitability of vessels for vascular access (VA). It's been previously validated in a clinical study. Here, AVAS performance was tested against multiple ultrasound mapping measurements using machine learning. A prospective multicentre international study (NCT04796558) with patient recruitment from March 2021-July 2024. Demographics, risk factors, vessels parameters, types of predicted and created VA (pVA, cVA) were collected. We modelled pVA and cVA using the Random Forest algorithm. Model performance was estimated and compared using Bayesian generalized linear models. ROC AUC with 95% credible intervals was the performance metric. 1151 patients were included. ROC AUC for pVA prediction by AVAS was 0.79 (0.77;0.82) and by mapping was 0.85 (0.83;0.88). ROC AUC for cVA prediction by AVAS was 0.71 (0.69;0.74) and by mapping was 0.8 (0.78;0.83). Using AVAS with other parameters increased the ROC AUC to 0.87 for pVA (0.84;0.89) and 0.82 (0.79;0.84) for cVA. Using mapping with other parameters increased the ROC AUC to 0.88 for pVA (0.86;0.91) and 0.85 (0.83;0.88) for cVA. Multiple mapping measurements showed higher performance at VA prediction than AVAS. However, AVAS is simpler and quicker, so may be preferable for routine clinical practice., Competing Interests: Declarations. Competing interests: The authors declare no competing interests. Ethical approval: The study was approved by Ethics Committee of University Hospital Královské Vinohrady in Prague, Czech Republic (EK-VP/06/0/2021)., (© 2025. The Author(s).)
- Published
- 2025
- Full Text
- View/download PDF
12. Outcomes of early cannulation arteriovenous graft versus PTFE arteriovenous graft in hemodialysis patients: A meta-analysis and systematic review.
- Author
-
Xiao Z, Rotmans JI, Letachowicz K, Franchin M, and D'Oria M
- Subjects
- Humans, Blood Vessel Prosthesis adverse effects, Polytetrafluoroethylene, Prosthesis Design, Risk Factors, Time Factors, Treatment Outcome, Vascular Patency, Arteriovenous Shunt, Surgical adverse effects, Arteriovenous Shunt, Surgical instrumentation, Arteriovenous Shunt, Surgical methods, Blood Vessel Prosthesis Implantation adverse effects, Blood Vessel Prosthesis Implantation instrumentation, Catheterization adverse effects, Catheterization instrumentation, Graft Occlusion, Vascular etiology, Graft Occlusion, Vascular physiopathology, Graft Occlusion, Vascular therapy, Kidney Failure, Chronic therapy, Renal Dialysis adverse effects, Renal Dialysis instrumentation, Renal Dialysis methods
- Abstract
Arteriovenous graft (AVG) is an alternative for hemodialysis (HD) patients with end-stage renal disease when their permanent vascular accesses fail. Since the last decades, the most widely used materials in these patients have been polytetrafluoroethylene (PTFE)-AVGs. Recently, several studies have reported that early cannulation (EC)-AVG can be an alternative to PTFE-AVG. This systematic review and meta-analysis aimed to compare the outcomes of EC-AVG and PTFE-AVG in HD patients. We searched the Ovid Embase, Ovid MEDLINE, and Cochrane Central Register of Controlled Trials for the relevant studies published from 01.01.2000 to 19.12.2022 by keywords and free words. All randomized controlled trials (RCTs) and observational cohort studies comparing EC-AVG with PTFE-AVG were included. Ten studies were included in analysis: one RCT, six retrospective cohort studies, and three prospective cohort studies. The results showed shorter cannulation intervals (four studies, 1116 participants: mean difference -23.62 days, 95% CI [-32.03, -15.21], p < 0.05) and less central venous catheter (CVC) usage (four studies, 733 participants: OR 0.20, 95% CI [0.04, 0.92], p < 0.05) for EC-AVG compared with PTFE-AVG, while comparable outcomes of primary patency (eight studies, 1712 participants: HR 0.89, 95% CI [0.70, 1.12]), primary assisted patency (five studies, 1355 participants: HR 1.13, 95% CI [0.70, 1.84]), secondary patency (nine studies, 1920 participants: HR 0.93, 95% CI [0.66, 1.31]), and infection risk (four studies, 640 participants: HR 1.12, 95% CI [0.48, 2.58]). When compared to PTFE-AVG in HD patients, EC-AVG seems to exhibit shorter cannulation intervals, less CVC usage, and comparable outcomes of graft patency, and infection risk., Competing Interests: Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
13. Validation of arteriovenous access stage (AVAS) classification: a prospective, international multicentre study.
- Author
-
Lawrie K, Waldauf P, Balaz P, Lacerda R, Aitken E, Letachowicz K, D'Oria M, Di Maso V, Stasko P, Gomes A, Fontainhas J, Pekar M, Srdelic A, and O'Neill S
- Abstract
Background: The arteriovenous access stage (AVAS) classification provides evaluation of upper extremity vessels for vascular access (VA) suitability. It divides patients into classes within three main groups: suitable for native fistula (AVAS1) or prosthetic graft (AVAS2), and patients not suitable for conventional native or prosthetic VA (AVAS3). We validated this system on a prospective dataset., Methods: A prospective, international observational study (NCT04796558) involved 11 centres from 8 countries. Patient recruitment was from March 2021 to January 2024. Demographic data, risk factors, vessels parameters, VA types, AVAS class and early VA failure were collected. Percentage agreement was used to assess predictive ability of AVAS (comparison of AVAS and created VA) and consistency of AVAS assessment between evaluators. Pearson's Chi-squared test was used for comparison of early failure rate of conventional (predicted by AVAS) and unconventional (not predicted by AVAS) VA., Results: From 1034 enrolled patients, 935 had arteriovenous fistula or graft, 99 patients did not undergo VA creation due opting for alternative renal replacement therapies, experiencing health complications, death or non-compliance. AVAS1 had 91.2%, AVAS2 7.2% and AVAS3 1.6% of patients. Agreement between evaluators was 89%. The most frequently created VAs were radial-cephalic (46%) and brachial-cephalic (27%) fistulae. The accuracy of AVAS versus created access was 79%. In comparison, VA predicted by clinicians versus created access was 62.1%. Inaccuracy of AVAS prediction was more common with higher AVAS classes, and the most common reason for inaccuracy was creation of distal VA despite less favourable anatomy (17%). Patients with unconventional VA had higher early failure rate than patients with conventional VA (20% vs 9.3%, respectively, P = .002)., Conclusion: AVAS is effective in predicting VA creation, but overall accuracy is reduced at higher AVAS classes when the complexity of decision-making increases and proximal vessels require preservation. When AVAS was followed by clinicians, early failure was significantly decreased., Competing Interests: None., (© The Author(s) 2024. Published by Oxford University Press on behalf of the ERA.)
- Published
- 2024
- Full Text
- View/download PDF
14. Severe Bullous Erysipelas/Cellulitis, Atypically Caused by Escherichia coli, in Kidney Transplant Recipient - Case Report and Review of Literature.
- Author
-
Maciej S, Hanna AB, Letachowicz K, Dorota K, Mirosław B, Oktawia M, and Magdalena K
- Subjects
- Humans, Escherichia coli Infections microbiology, Escherichia coli Infections drug therapy, Male, Escherichia coli isolation & purification, Anti-Bacterial Agents therapeutic use, Middle Aged, Immunocompromised Host, Kidney Transplantation adverse effects, Erysipelas drug therapy, Cellulitis microbiology, Cellulitis drug therapy
- Abstract
Erysipelas/cellulitis are severe skin infections that are especially dangerous for immunocompromised patients. The most common cause of these diseases is streptococcal infection, but sometimes they may be caused by other Gram-positive or negative bacteria or other factors. Proper diagnosis and treatment should be implemented accurately to prevent dangerous complications. We present a case of severe bullous erysipelas caused by Escherichia coli and discuss the diagnosis, differential diagnosis, and treatment of cellulitis in kidney transplant patients., Competing Interests: Declaration of competing interest All the authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
15. The long-term effect of a lung-ultrasound intervention on the risk for death, heart failure and myocardial infarction in dialysis patients.
- Author
-
Torino C, Mallamaci F, Sarafidis P, Papagianni A, Ekart R, Hojs R, Klinger M, Letachowicz K, Fliser D, Seiler-Mußler S, Lizzi F, Siamopoulos K, Balafa O, Ntounousi E, Slotki I, Shavit L, Stavroulopoulos A, Massy ZA, Seidowsky A, Battaglia Y, Martinez-Castelao A, Villalobos G, Fiaccadori E, Regolisti G, Hannedouche T, Bachelet T, Jager KJ, Dekker FW, Tripepi R, Tripepi G, Gargani L, Sicari R, Picano E, London GM, and Zoccali C
- Subjects
- Humans, Renal Dialysis adverse effects, Lung, Myocardial Infarction etiology, Heart Failure
- Published
- 2024
- Full Text
- View/download PDF
16. Point-of-Care Testing to Differentiate Various Acid-Base Disorders in Chronic Kidney Disease.
- Author
-
Gołębiowski T, Zmonarski S, Rożek W, Powązka M, Jerzak P, Gołębiowski M, Kusztal M, Olczyk P, Stojanowski J, Letachowicz K, Banasik M, Konieczny A, and Krajewska M
- Abstract
Background: Normal-anion-gap metabolic acidosis (AGMA) and high-anion-gap metabolic acidosis (HAGMA) are two forms of metabolic acidosis, which is a common complication in patients with chronic kidney disease (CKD). The aim of this study is to identify the prevalence of various acid-base disorders in patients with advanced CKD using point-of-care testing (POCT) and to determine the relationship between POCT parameters., Methods: In a group of 116 patients with CKD in stages G4 and G5, with a mean age of 62.5 ± 17 years, a sample of arterial blood was taken during the arteriovenous fistula procedure for POCT, which enables an assessment of the most important parameters of acid-base balance, including: pH, base excess (BE), bicarbonate (HCO
3 - ), chloride(Cl- ), anion gap (AG), creatinine and urea concentration. Based on this test, patients were categorized according to the type of acidosis-base disorder., Results: Decompensate acidosis with a pH < 7.35 was found in 68 (59%) patients. Metabolic acidosis (MA), defined as the concentration of HCO3 - ≤ 22 mmol/L, was found in 92 (79%) patients. In this group, significantly lower pH, BE, HCO3 - and Cl- concentrations were found. In group of MA patients, AGMA and HAGMA was observed in 48 (52%) and 44 (48%) of patients, respectively. The mean creatinine was significantly lower in the AGMA group compared to the HAGMA group (4.91 vs. 5.87 mg/dL, p < 0.05). The AG correlated positively with creatinine (r = 0.44, p < 0.01) and urea (r = 0.53, p < 0.01), but there was no correlation between HCO3 - and both creatinine (r = -0.015, p > 0.05) and urea (r = -0.07, p > 0.05). The Cl- concentrations correlated negatively with HCO3 - (r = -0.8, p < 0.01)., Conclusions: The most common type of acid-base disturbance in CKD patients in stages 4 and 5 is AGMA, which is observed in patients with better kidney function and is associated with compensatory hyperchloremia. The initiation of renal replacement therapy was significantly earlier for patients diagnosed with HAGMA compared to those diagnosed with AGMA. The more advanced the CKD, the higher the AG.- Published
- 2023
- Full Text
- View/download PDF
17. Radial Artery Deviation and Reimplantation (RADAR) to Accelerate the Maturation of Radial-Cephalic Fistulas for Hemodialysis in Patients with End-Stage Renal Disease.
- Author
-
Gołębiowski T, Kusztal M, Konieczny A, Gołębiowski M, Letachowicz K, Janczak D, and Krajewska M
- Abstract
Background: The most common form of vascular access for hemodialysis is a native arteriovenous fistula, which connects the site of the artery to the end of the vein. The maturation process of the fistula plays a crucial role in the establishment of a functional vascular access. Radial artery stenosis is among the potential causes of maturation failure. In these cases, improving the fistula's blood flow may be difficult, as traditional surgical reanastomosis and endovascular intervention frequently fail. Radial artery deviation and reimplantation (RADAR) is a novel and effective technique for creating primary fistulas with a high patency rate. The main disadvantage of this procedure is the ligation of the radial artery and the subsequent known consequences., Methods: To accelerate maturation, we used RADAR as a secondary approach in three patients with radial artery stenosis and maturation failure., Results: In all patients after surgery, we observed a significant increase in fistula blood flow. Two patients used fistulas for hemodialysis after surgery. We describe the image diagnosis, procedure, and benefits of this method., Conclusions: The RADAR technique may be successfully used as a secondary access in patients with maturation failure due to RA stenosis to accelerate fistula maturation.
- Published
- 2023
- Full Text
- View/download PDF
18. Native Renal Arteries Denervation as a Therapy of Refractory Hypertension in Patient after Heart and Kidney Transplantation-5 Years of Observation.
- Author
-
Pilch J, Mizera J, Wiśnicki K, Protasiewicz M, Kurcz J, Zmonarski S, Wawrzonkowski P, Letachowicz K, Kamińska D, Gołębiowski T, Zakliczyński M, Krajewska M, and Banasik M
- Abstract
This case report describes a 59-year-old male patient after heart and kidney transplantation, subsequently diagnosed with refractory hypertension since implemented antihypertensive pharmacotherapy consisting of six agents did not provide a substantial therapeutic response. Elevated blood pressure and its impact on a hypertrophied transplanted heart and impaired renal graft function have led to a significant deterioration in the patient's cardiovascular risk profile. To address this issue, a native renal arteries denervation was performed. It resulted in a noteworthy decrease in both systolic and diastolic pressure values, thus manifesting a positive hypotensive effect. Furthermore, a sustainable reduction of left ventricular mass and stabilization in kidney graft function were noticed. The presented case provides evidence that renal denervation can be an efficacious complementary treatment method in individuals who received kidney and heart grafts as it leads to a decrease in cardiovascular risk.
- Published
- 2023
- Full Text
- View/download PDF
19. High Plasma Angiopoietin-2 Levels Predict the Need to Initiate Dialysis within Two Years in Patients with Chronic Kidney Disease.
- Author
-
Szymczak A, Kusztal M, Gołębiowski T, Letachowicz K, Goździk A, Kościelska-Kasprzak K, Tukiendorf A, and Krajewska M
- Subjects
- Humans, Renal Dialysis, Prospective Studies, Vascular Cell Adhesion Molecule-1, Angiopoietin-2, Glomerular Filtration Rate physiology, Angiopoietin-1, Biomarkers, Vascular Endothelial Growth Factor C, Renal Insufficiency, Chronic
- Abstract
Volume status, congestion, endothelial activation, and injury all play roles in glomerular filtration rate (GFR) decline. In this study, we aimed to determine whether the plasma endothelial and overhydration markers could serve as independent predictors for dialysis initiation in patients with chronic kidney disease (CKD) 3b-5 (GFR < 45 mL/min/1.72 m
2 ) and preserved ejection fraction. A prospective, observational study in a single academic center was conducted from March 2019 to March 2022. Plasma levels of angiopoietin (Ang)-2, Vascular Endothelial Growth Factor-C (VEGF-C), Vascular Cell Adhesion Molecule-1 (VCAM-1), Copeptin (CPP), beta-trace protein (BTP), brain natriuretic peptide (BNP), and cardiac troponin I (cTnI) were all measured. Lung ultrasound (US) B-lines, bioimpedance, and echocardiography with global longitudinal strain (GLS) were recorded. The study outcome was the initiation of chronic dialysis (renal replacement therapy) during 24 months of follow-up. A total of 105 consecutive patients with a mean eGFR of 21.3 mL/min/1.73 m were recruited and finally analyzed. A positive correlation between Ang-2 and VCAM-1 and BTP was observed. Ang-2 correlated positively with BNP, cTnI, sCr, E/e', and the extracellular water (ECW)/intracellular water (ICW) ratio (ECW/ICW). After 24 months, a deterioration in renal function was observed in 47 patients (58%). In multivariate regression analysis, both VCAM-1 and Ang-2 showed independent influences on risk of renal replacement therapy initiation. In a Kaplan-Meier analysis, 72% of patients with Ang-2 concentrations below the median (3.15 ng/mL) survived without dialysis for two years. Such an impact was not observed for GFR, VCAM, CCP, VEGF-C, or BTP. Endothelial activation, quantified by plasma levels of Ang-2, may play a key role in GFR decline and the need for dialysis initiation in patients with CKD 3b, 4, and 5.- Published
- 2023
- Full Text
- View/download PDF
20. Dysnatremia in COVID-19 Patients-An Analysis of the COLOS Study.
- Author
-
Królicka A, Letachowicz K, Adamik B, Doroszko A, Kaliszewski K, Kiliś-Pstrusińska K, Kujawa K, Matera-Witkiewicz A, Madziarski M, Pomorski M, Protasiewicz M, Sokołowski J, Trocha M, Jankowska EA, and Madziarska K
- Abstract
Background: Sodium imbalance is one of the most common electrolyte disturbances encountered in the medical practice, and it may present with either hyponatremia or hypernatremia. Both sodium abnormalities are related with unfavorable outcomes., Objective: Elucidation of the prevalence of dysnatremia among COVID-19 patients and its impact on 30- and 90-day mortality and need for ICU admission was the goal., Design and Participants: A single-center, retrospective, observational study was conducted. A total of 2026 adult, SARS-CoV-2 positive patients, admitted to Wroclaw University Hospital between 02.2020 and 06.2021, were included. On admission, patients were divided into groups: normonatremic (N), hyponatremic (L), and hypernatremic (H). Acquired data was processed, and Cox hazards regression and logistic regression were implemented., Key Results: Hyponatremia on admission occurred in 17.47% ( n = 354) of patients and hypernatremia occurred in 5.03% ( n = 102). Dysnatremic patients presented with more comorbidities, used more drugs, and were statistically more often admitted to the ICU. Level of consciousness was the strongest predictor of ICU admission (OR = 1.21, CI: 1.16-1.27, p < 0.001). Thirty-day mortality was significantly higher in both the L and H groups (28.52%, p = 0.0001 and 47.95%, p < 0.0001, respectively), in comparison to 17.67% in the N group. Ninety-day mortality showed a similar trend in all study groups: 34.37% in the L group ( p = 0.0001), 60.27% ( p < 0.0001) in the H group, and 23.32% in the N group. In multivariable analyses, hypo- and hypernatremia were found to be independent predictors of 30- and 90-day mortality., Conclusions: Both hypo- and hypernatremia are strong predictors of mortality and disease severity in COVID-19 patients. Extraordinary care should be taken when dealing with hypernatremic, COVID-positive patients, as this group exhibits the highest mortality rates.
- Published
- 2023
- Full Text
- View/download PDF
21. The Influence of Healthy Habits on Cognitive Functions in a Group of Hemodialysis Patients.
- Author
-
Olczyk P, Jerzak P, Letachowicz K, Gołębiowski T, Krajewska M, and Kusztal M
- Abstract
(1) Background: Cognitive impairment (CI) is more prevalent in hemodialysis (HD) patients than in the general population. The purpose of this study was to examine if behavioral, clinical, and vascular variables are linked with CI in individuals with HD. (2) Methods: Initially, 47 individuals with chronic HD volunteered to participate in the trial, but only 27 patients ultimately completed the Montreal Cognitive Assessment (MoCA) and the Computerized Cognitive Assessment Tool (CompBased-CAT). We collected information on smoking, mental activities, physical activity (Rapid Assessment of Physical Activity, RAPA), and comorbidity. The oxygen saturation (rSO2) and pulse wave velocity (PWV; IEM Mobil-O-Graph) of the frontal lobes were measured. (3) Results: Significant associations were discovered between MoCA and rSO2 (r = 0.44, p = 0.02 and r = 0.62, p = 0.001, right/left, respectively), PWV (r = -0.69, p = 0.0001), CCI (r = 0.59, p = 0.001), and RAPA (r = 0.72, p = 0.0001). Those who actively occupied their time during dialysis and non-smokers achieved higher cognitive exam results. A multivariate regression study demonstrated that physical activity (RAPA) and PWV had separate effects on cognitive performance. (4) Conclusions: Cognitive skills are related to inter-dialysis healthy habits (physical activity, smoking) and intra-dialysis activities (tasks and mind games). Arterial stiffness, oxygenation of the frontal lobes, and CCI were linked with CI.
- Published
- 2023
- Full Text
- View/download PDF
22. The Usefulness of the COVID-GRAM Score in Predicting the Outcomes of Study Population with COVID-19.
- Author
-
Sebastian A, Madziarski M, Madej M, Proc K, Szymala-Pędzik M, Żórawska J, Gronek M, Morgiel E, Kujawa K, Skarupski M, Trocha M, Rola P, Gawryś J, Letachowicz K, Doroszko A, Adamik B, Kaliszewski K, Kiliś-Pstrusińska K, Matera-Witkiewicz A, Pomorski M, Protasiewicz M, Sokołowski J, Jankowska EA, and Madziarska K
- Subjects
- Anti-Bacterial Agents, C-Reactive Protein, Humans, Oxygen, Procalcitonin, Retrospective Studies, SARS-CoV-2, Troponin, COVID-19 epidemiology
- Abstract
Background: The COVID-GRAM is a clinical risk rating score for predicting the prognosis of hospitalized COVID-19 infected patients., Aim: Our study aimed to evaluate the use of the COVID-GRAM score in patients with COVID-19 based on the data from the COronavirus in the LOwer Silesia (COLOS) registry., Material and Methods: The study group (834 patients of Caucasian patients) was retrospectively divided into three arms according to the risk achieved on the COVID-GRAM score calculated at the time of hospital admission (between February 2020 and July 2021): low, medium, and high risk. The Omnibus chi-square test, Fisher test, and Welch ANOVA were used in the statistical analysis. Post-hoc analysis for continuous variables was performed using Tukey's correction with the Games-Howell test. Additionally, the ROC analysis was performed over time using inverse probability of censorship (IPCW) estimation. The GRAM-COVID score was estimated from the time-dependent area under the curve (AUC)., Results: Most patients (65%) had a low risk of complications on the COVID-GRAM scale. There were 113 patients in the high-risk group (13%). In the medium- and high-risk groups, comorbidities occurred statistically significantly more often, e.g., hypertension, diabetes, atrial fibrillation and flutter, heart failure, valvular disease, chronic kidney disease, and obstructive pulmonary disease (COPD), compared to low-risk tier subjects. These individuals were also patients with a higher incidence of neurological and cardiac complications in the past. Low saturation of oxygen values on admission, changes in C-reactive protein, leukocytosis, hyperglycemia, and procalcitonin level were associated with an increased risk of death during hospitalization. The troponin level was an independent mortality factor. A change from low to medium category reduced the overall survival probability by more than 8 times and from low to high by 25 times. The factor with the strongest impact on survival was the absence of other diseases. The medium-risk patient group was more likely to require dialysis during hospitalization. The need for antibiotics was more significant in the high-risk group on the GRAM score., Conclusion: The COVID-GRAM score corresponds well with total mortality. The factor with the strongest impact on survival was the absence of other diseases. The worst prognosis was for patients who were unconscious during admission. Patients with higher COVID-GRAM score were significantly less likely to return to full health during follow-up. There is a continuing need to develop reliable, easy-to-adopt tools for stratifying the course of SARS-CoV-2 infection.
- Published
- 2022
- Full Text
- View/download PDF
23. Liver Function Tests in COVID-19: Assessment of the Actual Prognostic Value.
- Author
-
Tokarczyk U, Kaliszewski K, Kopszak A, Nowak Ł, Sutkowska-Stępień K, Sroczyński M, Sępek M, Dudek A, Diakowska D, Trocha M, Gajecki D, Gawryś J, Matys T, Maciejiczek J, Kozub V, Szalast R, Madziarski M, Zubkiewicz-Zarębska A, Letachowicz K, Kiliś-Pstrusińska K, Matera-Witkiewicz A, Pomorski M, Protasiewicz M, Sokołowski J, Adamik B, Kujawa K, Doroszko A, Madziarska K, and Jankowska EA
- Abstract
Deviations in laboratory tests assessing liver function in patients with COVID-19 are frequently observed. Their importance and pathogenesis are still debated. In our retrospective study, we analyzed liver-related parameters: aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma-glutamyltransferase (GGT), total bilirubin (TBIL), albumin, comorbidities and other selected potential risk factors in patients admitted with SARS-CoV-2 infection to assess their prognostic value for intensive care unit admission, mechanical ventilation necessity and mortality. We compared the prognostic effectiveness of these parameters separately and in pairs to the neutrophil-to-lymphocyte ratio (NLR) as an independent risk factor of in-hospital mortality, using the Akaike Information Criterion (AIC). Data were collected from 2109 included patients. We created models using a sample with complete laboratory tests n = 401 and then applied them to the whole studied group excluding patients with missing singular variables. We estimated that albumin may be a better predictor of the COVID-19-severity course compared to NLR, irrespective of comorbidities (p < 0.001). Additionally, we determined that hypoalbuminemia in combination with AST (OR 1.003, p = 0.008) or TBIL (OR 1.657, p = 0.001) creates excellent prediction models for in-hospital mortality. In conclusion, the early evaluation of albumin levels and liver-related parameters may be indispensable tools for the early assessment of the clinical course of patients with COVID-19.
- Published
- 2022
- Full Text
- View/download PDF
24. Acute kidney injury secondary to urinary tract infection in kidney transplant recipients.
- Author
-
Królicki T, Bardowska K, Kudla T, Królicka A, Letachowicz K, Mazanowska O, Krajewski W, Poznański P, Krajewska M, and Kamińska D
- Subjects
- Aftercare, Humans, Patient Discharge, Retrospective Studies, Risk Factors, Transplant Recipients, Acute Kidney Injury complications, Acute Kidney Injury etiology, Kidney Transplantation adverse effects, Sepsis complications, Urinary Tract Infections complications, Urinary Tract Infections epidemiology
- Abstract
Acute kidney injury (AKI) in kidney transplant recipients (KTRs) is a common, yet poorly investigated, complication of urinary tract infections (UTI) and urosepsis. A retrospective comparative analysis was performed, recruiting 101 KTRs with urosepsis, 100 KTRs with UTI, and 100 KTRs without history of UTI or sepsis. The incidences of AKI in the urosepsis and UTI groups were 75.2% and 41%, respectively. The urosepsis group has also presented with a significantly higher prevalence of AKI stage 2 and 3 than the UTI group. The rates of recovery from AKI stages 1, 2 and 3, were 75,6%, 55% and 26.1%, respectively. Factors independently associated with renal recovery from AKI were: AKI severity grade (AKI stage 2 with OR = 0.25 and AKI stage 3 with OR = 0.1), transfusion of red blood cells (RBC) (OR = 0.22), and the use of steroid bolus in the acute phase of treatment (OR = 4). The septic status (urosepsis vs UTI) did not influence the rates of renal recovery from AKI after adjustment for the remaining variables. The dominant cause of RBC transfusions in the whole population was upper GI-bleeding. In multivariable analyses, the occurrence of AKI was also independently associated with a greater decline of eGFR at 1-year post-discharge and with a greater risk of graft loss. In KTRs with both urosepsis and UTI, the occurrence of AKI portends poor transplantation outcomes. The local transfusion policy, modulation of immunosuppression and stress ulcer prophylaxis (which is not routinely administered in KTRs) in the acute setting may be modifiable factors that significantly impact long-term transplantation outcomes., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
25. Prone Position Facilitates Creation of Ulnar-Basilic Arteriovenous Fistula.
- Author
-
Gołębiowski T, Jerzak P, Letachowicz K, Konieczny A, Kusztal M, Gołębiowski M, Banasik M, Sznajder K, and Krajewska M
- Abstract
Background: The distal ulnar-basilic arteriovenous fistula (UBAVF) is a rarely used alternative type of vascular access for haemodialysis. The location of the vein on the back aspect of the forearm forces an extremely uncomfortable external rotation of the upper limb during surgery when the patient is in a supine position., Methods: We present a new approach towards creating UBAVF, which involves placing the patient in the prone position, thus eliminating the aforementioned inconvenience. The procedure was performed and described in a 46-year-old patient with chronic kidney disease (CKD) due to diabetic nephropathy. In the period from September 2021 to December 2021, we created an additional three UBAVFs with such modifications., Results: All fistulas were patent both immediately after the procedure and 2 weeks after surgery., Conclusions: The prone position may improve the comfort of both the operator and the patient during the procedure. On top of this, it may have a positive impact on the quality of the arteriovenous anastomosis.
- Published
- 2022
- Full Text
- View/download PDF
26. Sex-Dependent Differences in Predictive Value of the C 2 HEST Score in Subjects with COVID-19-A Secondary Analysis of the COLOS Study.
- Author
-
Rola P, Doroszko A, Trocha M, Giniewicz K, Kujawa K, Skarupski M, Gajecki D, Gawryś J, Matys T, Szahidewicz-Krupska E, Adamik B, Kaliszewski K, Kiliś-Pstrusińska K, Matera-Witkiewicz A, Pomorski M, Protasiewicz M, Madziarski M, Chrostek U, Radzik-Zając J, Radlińska A, Zaleska A, Letachowicz K, Pisarek W, Barycki M, Sokołowski J, Jankowska EA, and Madziarska K
- Subjects
- Female, Humans, Male, Pandemics, Prognosis, Retrospective Studies, Risk Assessment, SARS-CoV-2, COVID-19
- Abstract
Background: Since the outbreak of the COVID-19 pandemic, a growing number of evidence suggests that COVID-19 presents sex-dependent differences in clinical course and outcomes. Nevertheless, there is still an unmet need to stratify the risk for poor outcome at the beginning of hospitalization. Since individual C
2 HEST components are similar COVID-19 mortality risk factors, we evaluated sex-related predictive value of the score. Material and Methods: A total of 2183 medical records of consecutive patients hospitalized due to confirmed SARS-CoV-2 infections were analyzed. Subjects were assigned to one of two of the study arms (male vs. female) and afterward allocated to different stratum based on the C2 HEST score result. The measured outcomes included: in-hospital -mortality, three-month- and six-month- all-cause-mortality and in-hospital non-fatal adverse clinical events. Results: The C2 HEST score predicted the mortality with better sensitivity in female population regarding the short- and mid-term. Among secondary outcomes, C2 HEST-score revealed predictive value in both genders for pneumonia, myocardial injury, myocardial infarction, acute heart failure, cardiogenic shock, and acute kidney injury. Additionally in the male cohort, the C2 HEST value predicted acute liver dysfunction and all-cause bleeding, whereas in the female arm-stroke/TIA and SIRS. Conclusion: In the present study, we demonstrated the better C2 HEST-score predictive value for mortality in women and illustrated sex-dependent differences predicting non-fatal secondary outcomes.- Published
- 2022
- Full Text
- View/download PDF
27. Cognitive Impairment in End Stage Renal Disease Patients Undergoing Hemodialysis: Markers and Risk Factors.
- Author
-
Olczyk P, Kusztal M, Gołębiowski T, Letachowicz K, and Krajewska M
- Subjects
- Humans, Renal Dialysis adverse effects, Risk Factors, Cognitive Dysfunction epidemiology, Cognitive Dysfunction etiology, Kidney Failure, Chronic therapy, Renal Insufficiency, Chronic complications, Renal Insufficiency, Chronic therapy
- Abstract
(1) Background: Cognitive impairment (CI) is common in chronic kidney disease (CKD) and patients treated with hemodialysis. (2) Methods: The systematic review was prepared following the PRISMA statement (2013). The biomedical electronic databases MEDLINE and SCOPUS were searched. (3) Results: out of 1093 studies, only 30, which met problem and population criteria, were included in this review. The risk factors for CI can be divided into three groups: traditional risk factors (present in the general population), factors related to dialysis sessions, and nontraditional risk factors occurring more frequently in the HD group. (4) Conclusions: the methods of counteracting CI effective in the general population should also be effective in HD patients. However, there is a need to develop unique anti-CI approaches targeting specific HD risk factors, i.e., modified hemodialysis parameters stabilizing cerebral saturation and blood flow.
- Published
- 2022
- Full Text
- View/download PDF
28. Mortality Predictive Value of the C 2 HEST Score in Elderly Subjects with COVID-19-A Subanalysis of the COLOS Study.
- Author
-
Rola P, Doroszko A, Trocha M, Giniewicz K, Kujawa K, Skarupski M, Gawryś J, Matys T, Szahidewicz-Krupska E, Gajecki D, Adamik B, Kaliszewski K, Kilis-Pstrusinska K, Letachowicz K, Matera-Witkiewicz A, Pomorski M, Protasiewicz M, Majchrzak K, Sokołowski J, Jankowska EA, and Madziarska K
- Abstract
Senility has been identified among the strongest risk predictors for unfavorable COVID-19-outcome. However, even in the elderly population, the clinical course of infection in individual patients remains unpredictable. Hence, there is an urgent need for developing a simple tool predicting adverse COVID-19-outcomes. We assumed that the C2HEST-score could predict unfavorable clinical outcomes in the elderly subjects with COVID-19-subjects., Methods: We retrospectively analyzed 1047 medical records of patients at age > 65 years, hospitalized at the medical university center due to COVID-19. Subsequently, patients were divided into three categories depending on their C2HEST-score result., Results: We noticed significant differences in the in-hospital and 3- month and 6- month mortality-which was the highest in high - risk -C2HEST-stratum reaching 35.7%, 54.4%, and 65.9%, respectively. The medium-risk -stratum mortalities reached 24.1% 43.4%, and 57.6% and for low-risk -stratum 14.4%, 25.8%, and 39.2% respectively. In the C2HEST-score model, a change from the low to the medium category increased the probability of death intensity approximately two-times. Subsequently, transfer from the low-risk to the high-risk -stratum raised all-cause-death-intensity 2.7-times. Analysis of the secondary outcomes revealed that the C2HEST-score has predictive value for acute kidney injury, acute heart failure, and cardiogenic shock., Conclusions: C2HEST-score analysis on admission to the hospital may predict the mortality, acute kidney injury, and acute heart failure in elderly subjects with COVID-19.
- Published
- 2022
- Full Text
- View/download PDF
29. Usefulness of the C 2 HEST Score in Predicting the Clinical Outcomes of COVID-19 in Diabetic and Non-Diabetic Cohorts.
- Author
-
Gajecki D, Doroszko A, Trocha M, Giniewicz K, Kujawa K, Skarupski M, Gawryś J, Matys T, Szahidewicz-Krupska E, Rola P, Stachowska B, Halupczok-Żyła J, Adamik B, Kaliszewski K, Kilis-Pstrusinska K, Letachowicz K, Matera-Witkiewicz A, Pomorski M, Protasiewicz M, Madziarski M, Konikowska K, Remiorz A, Orłowska M, Proc K, Szymala-Pedzik M, Zorawska J, Lindner K, Sokołowski J, Jankowska EA, and Madziarska K
- Abstract
Background: Diabetes mellitus is among the most frequent comorbidities worsening COVID-19 outcome. Nevertheless, there are no data regarding the optimal risk stratification of patients with diabetes and COVID-19. Since individual C
2 HEST components reflect the comorbidities, we assumed that the score could predict COVID-19 outcomes., Material and Methods: A total of 2184 medical records of patients hospitalized for COVID-19 at the medical university center were analyzed, including 473 diabetic patients and 1666 patients without any glucose or metabolic abnormalities. The variables of patients' baseline characteristics were retrieved to calculate the C2 HEST score and subsequently the diabetic and non-diabetic subjects were assigned to the following categories: low-, medium- or high-risk. The measured outcomes included: in-hospital mortality; 3-month and 6-month all-cause mortality; non-fatal end of hospitalization (discharged home/sudden-deterioration/rehabilitation) and adverse in-hospital clinical events., Results: A total of 194 deaths (41%) were reported in the diabetic cohort, including 115 in-hospital deaths (24.3%). The 3-month and 6-month in-hospital mortality was highest in the high-risk C2 HEST stratum. The C2 HEST score revealed to be more sensitive in non-diabetic-group. The estimated six-month survival probability for high-risk subjects reached 0.4 in both cohorts whereas for the low-risk group, the six-month survival probability was 0.7 in the diabetic vs. 0.85 in the non-diabetic group-levels which were maintained during whole observation period. In both cohorts, receiver operating characteristics revealed that C2 HEST predicts the following: cardiogenic shock; acute heart failure; myocardial injury; and in-hospital acute kidney injury., Conclusions: We demonstrated the usefulness and performance of the C2 HEST score in predicting the adverse COVID-19 outcomes in hospitalized diabetic subjects.- Published
- 2022
- Full Text
- View/download PDF
30. Lung Congestion Severity in Kidney Transplant Recipients Is Not Affected by Arteriovenous Fistula Function.
- Author
-
Letachowicz K, Królicka A, Tukiendorf A, Banasik M, Kamińska D, Gołębiowski T, Kuriata-Kordek M, Madziarska K, Mazanowska O, and Krajewska M
- Abstract
Lung ultrasound is a bedside technique for the assessment of pulmonary congestion. The study aims to assess the severity of lung congestion in kidney transplant recipients (KTR) in relation to arteriovenous fistula (AVF) patency. One hundred fifty-seven patients at least 12 months after kidney transplantation were recruited to participate in a cross-sectional study. Apart from routine visits, lung ultrasound at 28 typical points was performed. The patients were assigned to either AVF+ or AVF- groups. The mean number of lung ultrasound B-lines (USBLs) was 5.14 ± 4.96 with no differences between groups: 5.5 ± 5.0 in AVF+ and 4.8 ± 4.9 in AVF-, p = 0.35. The number and proportion of patients with no congestion (0-5 USBLs), mild congestion (6-15 USBLs), and moderate congestion (16-30 USBLs) were as follows: 101 (64.7%), 49 (31.4%), and 6 (3.8%), respectively. In multivariate analysis, only symptoms (OR 5.90; CI 2.43,14.3; p = 0.0001), body mass index (BMI) (OR 1.09; CI 1.03,1.17; p = 0.0046), and serum cholesterol level (OR 0.994; CI 0.998,1.000; p = 0.0452) contributed significantly to the severity of lung congestion. Lung ultrasound is a valuable tool for the evaluation of KTR. Functioning AVF in KTR is not the major factor affecting the severity of pulmonary congestion.
- Published
- 2022
- Full Text
- View/download PDF
31. Unintentional puncture of thyroid cyst during insertion of dialysis catheter.
- Author
-
Gołębiowski T, Konieczny A, Letachowicz K, Krajewska M, and Kusztal M
- Subjects
- Humans, Jugular Veins diagnostic imaging, Punctures, Renal Dialysis, Thyroid Gland, Catheterization, Central Venous adverse effects, Central Venous Catheters, Cysts diagnostic imaging, Cysts etiology, Cysts therapy
- Abstract
Central venous catheter (CVC) for hemodialysis are frequently implanted to the internal jugular vein. Thyroid cysts are commonly shown in ultrasound examination and their recognition should not pose a problem. Herby we present an uncommon case of the thyroid cyst unintended puncture, during an attempt of CVC insertion. No further clinical consequences were observed. For all practitioners, involved in interventional nephrology, such complication may be of the utmost importance.
- Published
- 2022
- Full Text
- View/download PDF
32. The Summarized Assessment of Endothelin A Receptor Expression in Renal Transplant Compartments Associated with Antibody-Mediated Rejection.
- Author
-
Banasik M, Kuriata-Kordek M, Donizy P, Nowańska K, Wiśnicki K, Letachowicz K, Zmonarski S, Kamińska D, Mazanowska O, Dawiskiba T, Janczak D, Hałoń A, Kepinska M, Uchmanowicz B, Zachciał J, Tukiendorf A, and Krajewska M
- Abstract
The occurrence of anti-endothelin A receptor antibodies may be useful in diagnosis of transplant damage. We noticed that the presence of the endothelin A receptor (ETA receptor) in biopsy compartments is yet to be defined. We decided therefore to analysed the presence and relevance of the ETA receptor in biopsy to define the cause. Our study aims to evaluate the expression of ETA receptors in renal recipients after a biopsy due to the worsening of transplant function., Methods: The expression of ETA receptors was analyzed in renal transplant biopsies using the immunohistochemical method. The evaluation of ETA receptors was performed on paraffin sections. ETA receptor expression was analyzed in four compartments of renal transplant biopsies: glomeruli; vessels; tubular epithelium; and interstitium. The assessment was presented using a three-step scale (0: lack of expression; 1: mild to moderate immunoreactivity; 2: high expression). The results of each compartment from a single biopsy were summarized and assessed in the context of antibody-mediated rejection (AMR)., Results: We analyzed 156 patients who had a renal allograft biopsy after renal transplantation. For each patient, we created a summarized ETA receptor expression score. The summarized ETA receptor expression score analysis showed statistically significant differences in patients with and without AMR. In addition, we noticed that patients with AMR had a significantly higher mean summarized expression of ETA receptor score of 3.28 ± 1.56 compared to patients who had a biopsy for other reasons with a mean summarized ETA receptor expression score of 1.47 ± 1.35 ( p < 0.000001). ROC analysis of the ETA receptor expression score for detecting AMR status showed that the most appropriate cut-off for the test of the chosen binary classifier is between 2 and 3 of the summarized ETA receptor expression score., Conclusions: The expression of endothelin A receptors in renal transplant compartments may be associated with antibody-mediated rejection. The positive ETA receptor staining might be a vital feature in the diagnosis of damage in AMR. The summarized ETA receptor expression score seems to be an exciting diagnostic tool in transplant injury assessment.
- Published
- 2021
- Full Text
- View/download PDF
33. The impact of location and patency of the arteriovenous fistula on quality of life of kidney transplant recipients.
- Author
-
Letachowicz K, Bardowska K, Królicki T, Kamińska D, Banasik M, Zajdel K, Mazanowska O, Madziarska K, Janczak D, and Krajewska M
- Subjects
- Adult, Aged, Arteriovenous Fistula etiology, Cross-Sectional Studies, Female, Heart Failure physiopathology, Humans, Hypertrophy, Left Ventricular physiopathology, Kidney Failure, Chronic therapy, Male, Middle Aged, Quality of Life, Renal Dialysis, Stroke Volume, Transplant Recipients, Vascular Patency, Ventricular Function, Left, Arteriovenous Fistula pathology, Arteriovenous Shunt, Surgical methods, Heart Failure complications, Hypertrophy, Left Ventricular complications, Kidney Transplantation adverse effects
- Abstract
Background: Arteriovenous fistulae (AVFs) may remain patent after kidney transplantation (KTx), contributing to maladaptive cardiac remodeling. The flow in AVFs is associated with the diameter of its vessels and thus with the AVF location. The main objective of this study is to assess the influence of AVF location and its patency on the self-reported quality of life (QOL) of kidney transplant recipients (KTRs) with past history of hemodialysis., Methods: To gain clinical data, during a scheduled visit, 353 KTRs were asked to fill out an anonymous questionnaire. From this group, 284 respondents were found eligible for analysis. The outcome was defined as prevalence of symptoms and health status, measured with the Left Ventricular Dysfunction-36 (LVD-36) Questionnaire in symptomatic patients., Results: The hemodialysis patients ( n = 243) were divided into two groups according to AVF location, i.e., DAVF - distally located AVF - ( n = 174) and PAVF - proximally located AVF - ( n = 69). The proportion of patients with heart failure (HF) was higher in PAVF group (24% vs. 12%, p = 0.0482). In the multivariable regression, PAVF, serum creatinine levels, and the presence of HF or coronary artery disease (CAD) remained independent predictors of lower functional capacity. Among patients with heart disease, the presence of active AVF was independently associated with worse functional outcome (higher LVD-36 scores)., Conclusions: The influence of persistent PAVF in KTRs seems to be unfavorable, especially when coexisting with CAD or HF. Abbreviations: AVF arteriovenous fistula; BMI body mass index; CAD coronary artery disease; D-AVF distally-located arteriovenous fistula; EC exercise capacity; HD hemodialysis; HF heart failure; KTx kidney transplantation; KTR kidney transplant recipient; LVD-36 Left Ventricle Disfunction - 36; LVEF left ventricle ejection fraction; LVH left ventricle hypertrophy; NYHA New York Heart Association; P-AVF proximally located arteriovenous fistula; PD peritoneal dialysis; PRO patient-reported outcomes; QOL quality of life.
- Published
- 2021
- Full Text
- View/download PDF
34. Pleural effusion with arm, breast, and face edema as a complication of subclavian vein catheterization and arteriovenous fistula in a patient after renal transplantation: A therapeutic approach.
- Author
-
Banasik M, Dawiskiba T, Letachowicz K, Zmonarski S, Mazanowska O, Lipiak E, Miś M, Janczak D, and Krajewska M
- Subjects
- Arm, Catheterization, Edema etiology, Edema therapy, Female, Humans, Middle Aged, Renal Dialysis, Subclavian Vein diagnostic imaging, Arteriovenous Fistula diagnostic imaging, Arteriovenous Fistula etiology, Arteriovenous Fistula therapy, Arteriovenous Shunt, Surgical adverse effects, Catheterization, Central Venous adverse effects, Kidney Transplantation adverse effects, Pleural Effusion diagnostic imaging, Pleural Effusion etiology, Pleural Effusion therapy
- Abstract
A 52-year-old woman after renal transplantation developed unilateral pleural effusion as well as a massive edema of the upper limb, breast, and face as a complication of the subclavian vein catheterization and arteriovenous fistula for hemodialysis. We revealed that impaired venous drainage due to extensive vein occlusion after temporary catheter insertion, together with high venous flow from the arteriovenous fistula, were the explanation. Because of moderately impaired renal graft function and limited availability of vascular access in the patient, fistula ligation as a therapeutic method described in literature, was not an option in our case. The patient underwent an unsuccessful attempt of venous angioplasty, and eventually banding of the fistula and blood flow reduction resolved pleural effusions and edema. This is a reasonable approach to the problem of massive upper torso edema due to central vein occlusion with ipsilateral arteriovenous fistula.
- Published
- 2021
- Full Text
- View/download PDF
35. Antimicrobial activity of hemodialysis catheter lock solutions in relation to other compounds with antiseptic properties.
- Author
-
Piątkowska E, Paleczny J, Dydak K, and Letachowicz K
- Subjects
- Bacteria pathogenicity, Biofilms drug effects, Catheter-Related Infections drug therapy, Catheter-Related Infections microbiology, Catheterization, Hemodialysis Solutions chemistry, Humans, Renal Dialysis adverse effects, Taurine analogs & derivatives, Taurine pharmacology, Thiadiazines pharmacology, Anti-Infective Agents pharmacology, Anti-Infective Agents, Local pharmacology, Bacteria drug effects, Catheter-Related Infections prevention & control, Central Venous Catheters microbiology
- Abstract
Proper protection of vascular access after haemodialysis is one of the key measures for the prevention of catheter-related infections. Various substances with bactericidal and anticoagulant properties are used to fill catheters, but due to the unsatisfactory clinical effects and occurrence of adverse reactions, the search for new substances is still ongoing. In the present paper, we compared the in vitro antimicrobial activity of solutions used for tunnelled catheter locking (taurolidine, trisodium citrate) and solutions of substances that could potentially be used for this purpose (sodium bicarbonate, polyhexanide-betaine). The studies have been conducted on bacteria that most commonly cause catheter-related infections. The values of both minimum inhibitory concentration and minimum biofilm eradication concentration of the substances were determined. The ability of the tested substances to eradicate biofilm from the dialysis catheter surface was also evaluated. The results showed that polyhexanide-betaine inhibited the growth of all microbes comparably to taurolidine, even after ≥ 32-fold dilution. The activity of trisodium citrate and sodium bicarbonate was significantly lower. Polyhexanide exhibited the highest activity in the eradication of bacterial biofilm on polystyrene plates. The biofilm formed on a polyurethane dialysis catheter was resistant to complete eradication by the test substances. Polyhexanide-betaine and taurolidine showed the highest activity. Inhibition of bacterial growth regardless of species was observed not only at the highest concentration of these compounds but also after dilution 32-128x (taurolidine) and 32-1024x (polyhexanide-betaine). Therefore, it can be assumed that taurolidine application as a locking solution prevents catheter colonization and systemic infection development. Taurolidine displays high antimicrobial efficacy against Gram-positive cocci as well as Gram-negative bacilli. On the contrary, the lowest antibacterial effect displayed product contained sodium bicarbonate. The inhibitions of bacterial growth were not satisfactory to consider it as a substance for colonization prevention. Polyhexanidine-betaine possessed potent inhibitory and biofilm eradication properties comparing to all tested products. PHMB is applied as a wound irrigation solution worldwide. However, based on our results, we assume that the PHMB is a promising substance for catheter locking solutions thanks to its safety and high antimicrobial properties., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2021
- Full Text
- View/download PDF
36. Vascular Access Perspectives in Patients After Kidney Transplantation.
- Author
-
Letachowicz K, Banasik M, Królicka A, Mazanowska O, Gołębiowski T, Augustyniak-Bartosik H, Zmonarski S, Kamińska D, Kuriata-Kordek M, and Krajewska M
- Abstract
Introduction: More attention has been paid to the influence of arteriovenous fistula (AVF) on the cardiovascular system. In renal transplant recipients, some beneficial effect of an elective vascular access (VA) ligation was observed in patients with a high AVF flow. However, this strategy is not widely accepted and is in contradiction to the rule of vasculature preservation for possible future access. The aim of our study is to elucidate the vascular access function and VA perspective in the kidney transplantation (KTx) population. Materials and Methods: KTx patients with a stable graft function were recruited to participate in this single center observational study (NCT04478968). The measurement of VA flow and vessel mapping for future vascular access was performed by a color Doppler ultrasound. The study group included 99 (63%) males and 58 (37%) females; the median age was 57 (IQR 48-64) years. The median time from the transplantation to the baseline visit was 94 (IQR 61-149) months. Median serum creatinine concentration was 1.36 (IQR 1.13-1.67) mg/dl. Results: Functioning VA was found in 83 out of 157 (52.9%) patients. The sites were as follows: snuffbox in six (7.2%), wrist in 41 (49.4%), distal forearm in 18 (21.7%), middle or proximal forearm in eight (9.6%), upper-arm AV graft in one (1.2%), and upper-arm AVFs in nine (10.8%) patients, respectively. Blood flow ranged from 248 to 7,830 ml/min; the median was 1,134 ml/min. From the transplantation to the study visit, 66 (44.6%) patients experienced access loss. Spontaneous thrombosis was the most common, and it occurred in 60 (90.9%) patients. The surgical closure of VA was performed only in six (4%) patients of the study group with a functioning VA at the time of transplantation. Access loss occurred within the 1st year after KTx in 33 (50%) patients. Majority (50 out of 83, 60.2%) of the patients with an active VA had options to create a snuffbox or wrist AVF on the contralateral extremity. In a group of 74 patients without a functioning VA, the creation of a snuffbox or wrist AVF on the non-dominant and dominant extremity was possible in seven (9.2%) and 40 (52.6%) patients, respectively. In 10 (13.1%) patients, the possibilities were limited only to the upper-arm or proximal forearm VA on both sides. Access ligation was considered by 15 out of 83 (18.1%) patients with a patent VA. Conclusions: In the majority of the patients, vascular access blood flow was below the threshold of the negative cardiovascular effect of vascular access. Creation of a distal AVF is a protective measure to avoid a high flow and preserve the vessels for future access. The approach to VA should be individualized and adjusted to the patient's profile., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Letachowicz, Banasik, Królicka, Mazanowska, Gołębiowski, Augustyniak-Bartosik, Zmonarski, Kamińska, Kuriata-Kordek and Krajewska.)
- Published
- 2021
- Full Text
- View/download PDF
37. Partial breakage of a tunneled dialysis catheter: An uncommon finding.
- Author
-
Letachowicz K, Gołębiowski T, Miś M, Wolańczyk M, Zmonarski S, and Krajewska M
- Subjects
- Catheters, Indwelling adverse effects, Humans, Renal Dialysis adverse effects, Catheterization, Central Venous adverse effects, Central Venous Catheters
- Abstract
Infections and dysfunction are the most common complications related to catheter use. Here we describe a case of catheter rupture on the course of subcutaneous channel. Catheter fractures are relatively rare, but potentially hazardous complications. In case of partial breakage, a catheter exchange should be a simple solution., (© 2020 International Society for Hemodialysis.)
- Published
- 2021
- Full Text
- View/download PDF
38. Carotid artery tortuosity may pose a problem during insertion of the tunneled catheter for hemodialysis.
- Author
-
Gołębiowski T, Poznański P, Kusztal M, Miś M, Szczurowska A, Letachowicz K, Konieczny A, Majchrzak K, Janczak D, and Krajewska M
- Subjects
- Aged, Carotid Arteries diagnostic imaging, Carotid Arteries surgery, Computed Tomography Angiography, Humans, Imaging, Three-Dimensional, Kidney Failure, Chronic therapy, Male, Renal Dialysis, Risk Factors, Ultrasonography, Doppler, Color, Vascular Malformations complications, Carotid Arteries abnormalities, Catheterization, Central Venous adverse effects, Catheters, Indwelling adverse effects, Central Venous Catheters adverse effects, Vascular Malformations diagnosis
- Abstract
Tortuosity of the carotid artery is usually an asymptomatic vascular abnormality and is discovered accidentally during cerebral angiography. These vascular changes may aggravate surgical procedures in the neck region. We described a technique of permanent catheter insertion in patients with renal graft failure in whom renal replacement therapy was necessary. Severe tortuosity of cervical arteries may make this procedure more difficult, necessitating a special technique, that is, full image monitoring., (© 2020 International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
39. Exhausted Capacity of Bicarbonate Buffer in Renal Failure Diagnosed Using Point of Care Analyzer.
- Author
-
Gołębiowski T, Kusztal M, Konieczny A, Kuriata-Kordek M, Gawryś A, Augustyniak-Bartosik H, Letachowicz K, Zielińska D, Wiśniewska M, and Krajewska M
- Abstract
Background: Metabolic acidosis in patients with chronic kidney disease (CKD) is a common complication. A bicarbonate concentration in venous blood (V-HCO
3 - ) is a key index for diagnosis and treatment initiation. The aim of our study is to evaluate usability of acid-base balance parameters of in blood taken simultaneously from peripheral artery and the vein., Methods: A total of 49 patients (median age 66 years [interquartile range IQR 45-75]), with CKD stage G4 or G5 were enrolled in this cross-sectional study. All patients were qualified for arteriovenous fistula creation in pre-dialysis period. The samples were taken during surgery, directly after dissection, and evaluated in a point of care testing analyzer. The arteriovenous difference in bicarbonate levels (Δ-HCO3 - ) was calculated. According to glomerular filtration rate (eGFR) the group was divided into Group A eGFR ≥ 10 mL/min/1.73 m2 ) and Group B eGFR < 10 mL/min/1.73 m2 )., Results: In Group A Δ-HCO3 - was significantly higher compared to Group B. No such differences were observed in the case of V-HCO3 - . Δ-HCO3 - positively correlated with eGFR. The discriminative power of Δ-HCO3 - for predicting eGFR < 10 mL/min/1.73 m2 was 0.72 (95% confidence interval [CI] = 0.551-0.88; p = 0.01) which provided 67% sensitivity and 75% specificity. The best cut-off was 0.5 mmol/L., Conclusions: The Δ-HCO3 - lower than 0.5 mmol/L may be used as predictor of exhaust buffer capacity. The value of this tool should be tested in larger population.- Published
- 2021
- Full Text
- View/download PDF
40. Endothelin A Receptors Expressed in Glomeruli of Renal Transplant Patients May Be Associated with Antibody-Mediated Rejection.
- Author
-
Nowańska K, Banasik M, Donizy P, Kościelska-Kasprzak K, Zmonarski S, Letachowicz K, Kamińska D, Mazanowska O, Augustyniak-Bartosik H, Tukiendorf A, Chudiak A, Dawiskiba T, Hałoń A, and Krajewska M
- Abstract
Background: Non-human leukocyte antigen (HLA) anti-endothelin A receptor antibodies are presented as being potentially important, but the expression of the endothelin A receptor in glomeruli (ETA receptor (g+)) has not yet been described. We decided to evaluate the presence and relevance of the ETA receptor in for-cause renal transplant biopsies. The aim of our study was to evaluate the immunoreactivity of the ETA receptor and its significance in patients who underwent a renal transplant biopsy due to the deterioration of transplant function, with detailed characterization of staining in glomeruli., Methods: The immunohistochemical expression of ETA receptor (ETAR) was analyzed in renal transplant biopsies. Microscopic evaluation was performed on paraffin sections in glomeruli. The analysis was performed using a two-step scale (0: lack of ETAR expression; 1: the presence of ETAR expression-mild to moderate immunoreactivity)., Results: We analyzed 149 patients who underwent renal allograft biopsy after renal transplantation. Positive staining of ETA receptors in glomeruli (ETA receptor (g+)) was noticed in 13/149 (8.7%) patients. Five of these 13 (38.5%) patients with ETA receptor (g+) developed antibody-mediated rejection (AMR), while 13 of the remaining 136 (9.5%) ETA receptor (g-) patients developed AMR ( p = 0.0022). Graft loss was noticed in all but one ETA receptor (g+) patient with AMR (4/5; 80%), but only in 2/13 (15%) ETA receptor (g-) patients with AMR ( p = 0.009) during the first year after biopsy., Conclusions: The expression of endothelin A receptors in glomeruli seems to be a potentially important feature in the diagnosis of damage during antibody-mediated rejection. It may help to identify patients at a higher risk of allograft rejection and injury.
- Published
- 2021
- Full Text
- View/download PDF
41. Simultaneous placement of leadless pacemaker and dialysis catheter in patient with exhausted vasculature.
- Author
-
Bednarczyk D, Kuliczkowski W, Letachowicz K, Dzidowski M, Witkowski T, Krajewska M, Kusztal M, Mysiak A, Ściborski K, and Mitkowski P
- Subjects
- Device Removal, Humans, Male, Middle Aged, Prosthesis-Related Infections diagnosis, Prosthesis-Related Infections microbiology, Punctures, Treatment Outcome, Cardiac Pacing, Artificial, Catheterization, Central Venous instrumentation, Catheterization, Peripheral instrumentation, Catheters, Indwelling, Central Venous Catheters, Femoral Vein diagnostic imaging, Jugular Veins diagnostic imaging, Pacemaker, Artificial adverse effects, Prosthesis-Related Infections therapy, Renal Dialysis
- Abstract
The problem with limited venous access may occur in patients receiving long-term hemodialysis treatment with no possibility of arteriovenous access or in patients with cardiac implantable electronic device-related infection leading to the removal of cardiac implantable electronic device. We present a case report where both situations occur simultaneously. Using recent development in cardiac pacing-leadless cardiac pacemaker-we manage to overcome the vascular access problem. The described case emphasizes the necessity of multispecialty collaboration and gains of new pacing technology in patients who need placement of vascular access for hemodialysis and cardiac implantable electronic device where vascular access is scarce.
- Published
- 2021
- Full Text
- View/download PDF
42. The Global Longitudinal Strain in Renal Transplant Recipients and Immunosuppressive Regimen.
- Author
-
Obremska M, Szymczak M, Letachowicz K, Zyśko D, Boratyńska M, Łukaszewski M, and Krajewska M
- Subjects
- Aged, Female, Glomerular Filtration Rate, Humans, Immunosuppression Therapy methods, Immunosuppressive Agents adverse effects, Kidney physiopathology, Male, Middle Aged, Postoperative Complications etiology, Prognosis, Renal Dialysis, Retrospective Studies, Systole, Ventricular Dysfunction, Left etiology, Ventricular Function, Left, Echocardiography methods, Immunosuppression Therapy adverse effects, Kidney Transplantation adverse effects, Postoperative Complications diagnosis, Stroke Volume, Ventricular Dysfunction, Left diagnosis
- Abstract
Background: Echocardiographic global longitudinal strain (GLS) has recently been considered as a more effective assessment than the ejection fraction (EF) in detecting subtle changes of left ventricular (LV) systolic function. The aim of the study is to compare GLS in renal transplant recipients (RTrs) with preserved LVEF, depending on the recipient's immunosuppressive regimen. The impaired GLS was considered to be > -18%., Methods: A total of 84 RTrs were divided into 2 groups depending on immunosuppressive regimen: group 1, which included 32 patients (aged 62.3 ± 7.5) receiving mammalian target of rapamycin inhibitors, and group 2, which included 52 patients (aged 58.9 ± 13.9 treated with calcineurin inhibitors. In all patients, echocardiography was performed, including calculation of GLS, and laboratory and clinical markers of cardiovascular risk were assessed., Results: The frequency of men was significantly higher in group 1 (P = .01). There were no differences between the groups in age, body mass index, frequency of diabetes, hypertension, time of hemodialysis (HD) before kidney transplantation (KTx), time after KTx, concentration of cholesterol and creatinine, echocardiographic linear parameters, and LV mass. The estimated glomerular filtration rate and triglyceride concentration were significantly higher in group 1. The mean value of GLS was similar in both groups (-19.8 [-3.5] vs -18.9 [-3.0]; P = .22). The multivariate logistic regression analysis revealed that duration of HD > 26 months is associated with GLS ≥ -18% (odds ratio 2.95, 95% CI 1.08-7.99, P = .03) CONCLUSIONS: The frequency of impaired GLS in RTr was similar regardless of the type of the immunosuppressive regimen. The impaired GLS was associated with duration of HD before KTx., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
43. Arterial Stiffness Assessed by Oscillometric Method in Kidney Transplant, Predialysis, and Dialysis Patients.
- Author
-
Olczyk P, Małyszczak A, Gołębiowski T, Letachowicz K, Szymczak A, Mazanowska O, Krajewska M, and Kusztal M
- Subjects
- Adult, Arteries physiopathology, Cross-Sectional Studies, Female, Heart Rate, Humans, Male, Middle Aged, Oscillometry, Postoperative Complications etiology, Pulse Wave Analysis, Renal Insufficiency, Chronic complications, Renal Insufficiency, Chronic therapy, Risk Factors, Cardiovascular Diseases etiology, Kidney Transplantation adverse effects, Renal Dialysis adverse effects, Renal Insufficiency, Chronic physiopathology, Vascular Stiffness
- Abstract
Introduction: Chronic kidney disease (CKD) is strongly associated with a higher risk of cardiovascular disease (CV). An important nontraditional risk factor of cardiovascular disease in renal patients is vascular stiffness, which currently can be evaluated by oscillometric measuring of pulse wave velocity (PWV) and heart rate-corrected augmentation index (AIx@75)., Aim: The aim of our study was to compare vascular stiffness between kidney transplant (KTx) recipients, patients on dialysis maintenance, and those in the predialysis period., Materials and Methods: A cross-sectional study of 140 patients (52 in CKD stage 3-4; 37 in CKD stage 5 on hemodialysis maintenance [HD]; and 51 KTx recipients) had their PWV and AIx@75 measured with Mobil-O-Graph (IEM Gmbh, Stolberg, Germany) blood and pulse pressure monitor., Results: KTx, HD, and CKD G3-4 were comparable in term of age, sex, body mass index, and diagnoses of diabetes mellitus and hypertension. The PWV was higher in the HD group than in the KTx and CKD G3-4 (9.4 m/s vs 8.4 m/s vs 7.9 m/s respectively; P < .05 for HD vs other groups), while the difference between the KTx and CKD G3-4 was not significant. AIx@75 values were similar in the HD and KTx groups (27.1 and 25.6; P > .05) and significantly lower in CDK G3-4 (17.8; P < .05)., Conclusions: According to our results, the highest CV risk expressed by PWV (vascular stiffness) was found in hemodialysis patients. Although patients with CKD 3-4 and after KTx showed comparable large artery stiffness, transplant recipients additionally showed higher stiffness in smaller arteries as measured by heart rate-corrected AIx., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
44. Toll-Like 4 Receptor Expression on Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Can Help to Indicate the Risk of Graft Deterioration in Patients Who Experienced an Episode of Symptomatic Cytomegalovirus Infection.
- Author
-
Zmonarski SC, Banasik M, Gołębiowski T, Letachowicz K, Madziarska K, Żabińska M, Zmonarska J, Mazanowska O, and Krajewska M
- Subjects
- Adult, Cyclosporine blood, Cytomegalovirus Infections virology, Female, Glomerular Filtration Rate, Graft Rejection virology, Humans, Kidney virology, Male, Middle Aged, Tacrolimus blood, Cytomegalovirus Infections genetics, Graft Rejection genetics, Kidney Transplantation adverse effects, Leukocytes, Mononuclear metabolism, Toll-Like Receptor 4 blood
- Abstract
Data binding the expression of Toll-like 4 receptor (TLR4), transplanted kidney (KT) function, and symptomatic CMV infection (CMV+) are scarcely available., Objective: To investigate the relationship between TLR4 expression (TLR4ex) in patients who had a relapse of CMV and transplant function., Materials and Methods: TLR4ex was measured in peripheral blood mononuclear cells of KT recipients. We compared TLR4ex among 30 CMV+ patients and 87 patients without CMV infection (CMVneg). At the beginning (day 0) TLR4ex, as well as concentrations of cyclosporin A and tacrolimus were determined. All patients, CMV+ and CMVneg patients were divided according to the respective median of TLR4ex into groups of low-TLR4 expression (L-TLR4ex) and high-TLR4 expression (H-TLR4ex). Estimated glomerular filtration rate (EGFR) was assessed on day 0 and after the follow-up (F-up). The magnitudes of EGFR change (ΔEGFR) were evaluated. Stable treatment along the F-up period (median 11.9 months) was applied., Results: TLR4ex of CMV+ in 67% was below median for all patients. For day 0, in CMV+: no link of TLR4ex with EGFR was found; TLR4ex was lower but day 0 EGFR did not differ from H-TLR4ex. In CMVneg, a GFR-TLR4ex link was present. Post F-up. In CMV+ with L-TLR4ex, EGFR declined, with no change in H-TLR4ex. In CMVneg with H-TLR4ex, EGFR increased, with no change in L-TLR4ex. Both regression and receiver operating characteristic curve analyses points out the impact of CMV+ and TLR4ex on eGFR and ΔEGFR., Conclusion: In CMV+, low TLR4ex increases the risk of EGFR deterioration. In CMVneg, high TLR4ex raises the chance of EGFR improvement., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
45. Toll-like 4 receptor (TLR4) expression on peripheral blood mononuclear cells in renal transplant recipients with pre-transplant chronic interstitial nephritis indicates patients at risk of graft deterioration.
- Author
-
Zmonarski SC, Banasik M, Golebiowski T, Madziarska K, Mazanowska O, Myszka M, Zmonarska J, Letachowicz K, Dawiskiba T, and Krajewska M
- Subjects
- Adult, Chronic Disease, Female, Gene Expression Regulation, Graft Rejection epidemiology, Humans, Male, Middle Aged, Poland epidemiology, Risk, Toll-Like Receptor 4 genetics, Young Adult, Graft Rejection diagnosis, Kidney Transplantation, Leukocytes, Mononuclear metabolism, Nephritis, Interstitial therapy, Toll-Like Receptor 4 metabolism, Transplant Recipients
- Abstract
Data binding the expression of Toll-like 4 receptor (TLR4ex), transplanted kidney function, and the cause of pre-transplant end-stage renal disease are scarcely available., Objective: To investigate the relationship between pre-transplant chronic interstitial nephritis (CIN), TLR4ex and transplanted kidney function., Materials and Methods: TLR4ex was measured in peripheral blood mononuclear cells of 43 CIN kidney transplant recipients. We compared TLR4ex among 33 patients with pre-transplant chronic non-infectious interstitial nephritis (NIN) and 10 patients with pre-transplant chronic pyelonephritis (Py). At the beginning (Day-0) TLR4ex, as well as concentrations of cyclosporin A (CyA) and tacrolimus (TAC) were determined. Both CIN and NIN patients were divided according to the respective median of TLR4ex into groups of low-TLR4 expression (L-TLR4ex) and high-TLR4 expression (H-TLR4ex). Serum creatinine/glomerular filtration rate (sCr/EGFR) was assessed on Day-0 and after the follow-up (F-up). The magnitudes of sCr/EGFR change (ΔsCr/ΔEGFR) were evaluated. The treatment was maintained stable along the F-up period (median 11.9 months)., Results: Day-0: in CIN with L-TLR4ex TAC was lower but sCr/EGFR were not different from H-TLR4ex; in Py TLR4ex and TAC were lower than in NIN with no difference in sCR/eGFR. After F-up: in CIN with L-TLR4ex sCR/EGFR and ΔsCr/ΔEGFR were worse than in H-TLR4ex; in Py sCR/EGFR and ΔsCr/ΔEGFR were worse than in NIN. The regression analysis points out prospective impact of Py and TLR4ex on sCR/eGFR and ΔsCr/ΔeGFR., Conclusion: In CIN, both TLR4ex and Tac appear to be a useful positive predictor of the effectiveness of immunosuppression. Chronic pyelonephritis indirectly promotes faster progression of chronic transplanted kidney disease., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
46. The attitude of kidney transplant recipients towards elective arteriovenous fistula ligation.
- Author
-
Bardowska K, Letachowicz K, Kamińska D, Kusztal M, Gołębiowski T, Królicki T, Zajdel K, Mazanowska O, Janczak D, and Krajewska M
- Subjects
- Adult, Elective Surgical Procedures, Esthetics, Female, Forearm, Humans, Kidney Failure, Chronic surgery, Kidney Failure, Chronic therapy, Ligation, Male, Middle Aged, Patient Education as Topic, Renal Dialysis, Surveys and Questionnaires, Thrombosis etiology, Thrombosis prevention & control, Arteriovenous Shunt, Surgical adverse effects, Attitude to Health, Kidney Transplantation, Patient Preference, Transplant Recipients psychology
- Abstract
Background: Arteriovenous fistulas (AVF) are a source of various complications. Among previously hemodialyzed kidney transplant recipients (KTxR), the AVF may persist over time. The patients' decisions whether to ligate the functioning AVF may be prompted by many factors. Our knowledge of benefits concerning the procedure as well as patients' attitude towards it is scarce., Aim: Evaluation of the patients' opinion on the persistent AVF ligation after a successful kidney transplantation., Materials and Methods: An anonymous survey was carried out among 301 previously hemodialyzed KTxR. The patients were recruited during scheduled visits in the Transplantation Outpatient Unit. All subjects completed an anonymous questionnaire including questions about their attitude towards the matter in question., Results: 69 patients (22.9%) have considered AVF closure. The most common causes for such attitude were esthetic reasons (n = 29) and concerns about heart health (n = 13). Among those 69 subjects, 18 have presented with symptomatic AVF due to multiple symptoms. Symptomatic AVFs were localized on the forearm in 14 out of 18 cases. As many as 116 (38.5%) cases have never wanted to ligate the AVF and 116 (38.5%) subjects did not have a clear opinion. In our study we report 158 (52.5%) cases of non-functioning AVFs. The main reason for the above was spontaneous AVF thrombosis (121 cases). Only 24 subjects reported to rely on the physician-provided information about the AVF management., Conclusions: One fourth of KTRs have ever considered AVF ligation. There is a distinct need for educating patients on the possibilities of post-transplantation AVF management., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2020
- Full Text
- View/download PDF
47. Disability of Dialysis Patients and the Condition of Blood Vessels.
- Author
-
Gołębiowski T, Kusztal M, Konieczny A, Letachowicz K, Gawryś A, Skolimowska B, Ostrowska B, Zmonarski S, Janczak D, and Krajewska M
- Abstract
The number of elderly hemodialysis patients is constantly increasing worldwide. This population has a high burden of comorbid conditions, which impair daily activities. The aim of the study was to analyze problems of disability in hemodialysis patients in the context of cardiovascular (CV) complications and vascular condition. In this cross-sectional study, 129 patients (mean age 64.5) were enrolled. The degree of disability in Barthel index (Bi) and 10-year cardiovascular risk (QRISK
® 3) were assessed. A Mobil-O-Graph monitor was used for measuring hemodynamic parameters. Only 6.2% of patients were professionally active, 19% used a wheelchair for transport, and 16% used crutches. More than half (51%) were independent in everyday activities reaching 80-100 points on Bi. The rest, with Bi < 80, were considered as dependent. The most common causes of disability were CV complications. The independent group (80-100 points) was characterized by significantly lower pulse wave velocity (PWV) and lower QRISK® 3 compared to dependent patients. The degree of disability negatively correlated with age, PWV, and QRISK® 3. Multivariate logistic regression revealed that disability (Bi < 80) was independently associated with CV events in the past adjusted odds ratio (adj.OR) 4.83 (95% confidence interval (95% CI): 1.74-13.41) and higher PWV adj.OR 1.45 (95% CI: 1.15-1.82). Our results indicate that CV diseases are the most important cause of functional impairment.- Published
- 2020
- Full Text
- View/download PDF
48. Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study.
- Author
-
Torino C, Gargani L, Sicari R, Letachowicz K, Ekart R, Fliser D, Covic A, Siamopoulos K, Stavroulopoulos A, Massy ZA, Fiaccadori E, Regolisti G, Bachelet T, Slotki I, Martinez-Castelao A, Coudert-Krier MJ, Rossignol P, Hannedouche T, Wiecek A, Sarafidis P, Battaglia Y, Prohić N, Klinger M, Hojs R, Seiler-Mußler S, Lizzi F, Siriopol D, Balafa O, Shavit L, Loutradis C, Seidowsky A, Tripepi R, Mallamaci F, Tripepi G, Picano E, London GM, and Zoccali C
- Subjects
- Humans, Inflammation, Longitudinal Studies, Lung diagnostic imaging, Renal Dialysis adverse effects, Pulmonary Edema diagnostic imaging, Pulmonary Edema etiology
- Abstract
Introduction: Since inflammation alters vascular permeability, including vascular permeability in the lung, we hypothesized that it can be an amplifier of lung congestion in a category of patients at high risk for pulmonary oedema like end stage kidney disease (ESKD) patients., Objective and Methods: We investigated the effect modification by systemic inflammation (serum CRP) on the relationship between a surrogate of the filling pressure of the LV [left atrial volume indexed to the body surface area (LAVI)] and lung water in a series of 220 ESKD patients. Lung water was quantified by the number of ultrasound B lines (US-B) on lung US. Six-hundred and three recordings were performed during a 2-year follow up. Longitudinal data analysis was made by the Mixed Linear Model., Results: At baseline, 88 had absent, 101 had mild to moderate lung congestion and 31 severe congestion. The number of US B lines associated with LAVI (r = 0.23, P < 0.001) and serum CRP was a robust modifier of this relationship (P < 0.001). Similarly, in fully adjusted longitudinal analyses US-B lines associated with simultaneous estimates of LAVI (P = 0.002) and again CRP was a strong modifier of this relationship in adjusted analyses (P ≤ 0.01). Overall, at comparable LAVI levels, lung congestion was more pronounced in inflamed than in non-inflamed patients., Conclusion: In ESKD systemic inflammation is a modifier of the relationship between LAVI, an integrate measure of LV filling pressure, and lung water. For any given pressure, lung water is increased with higher CRP levels, likely reflecting a higher permeability of the alveolar-capillary barrier.
- Published
- 2020
- Full Text
- View/download PDF
49. Dialysis Catheter Insertion with Extended Ultrasound Monitoring.
- Author
-
Letachowicz K, Goździk A, Gołębiowski T, Letachowicz W, Kusztal M, Szymczak A, Zmonarski S, Kanafa M, Janczak D, and Krajewska M
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Heart Atria diagnostic imaging, Humans, Male, Middle Aged, Retrospective Studies, Catheterization, Central Venous, Catheters, Indwelling, Echocardiography, Renal Dialysis, Vena Cava, Inferior diagnostic imaging
- Abstract
Introduction: Dialysis catheter insertion is a routine procedure performed when there is necessity of urgent renal replacement therapy initiation. Due to limited access, higher costs, and long waiting times for fluoroscopy, alternative visualization methods are introduced into clinical practice. One of the most promising is transthoracic echocardiographic monitoring of guide-wire introduction., Objective: The feasibility of the technique was verified by nephrologists inserting dialysis catheters., Methods: A single center prospective trial was performed (NCT03727581). Introduction of guide-wire was monitored with ultrasound to confirm correct position of the wire in the inferior vena cava (IVC) or right atrium (RA). The study group included 30 patients, 19 males and 11 females, 25-83 years old., Results: It was possible to obtain a good picture of IVC in the majority of patients. In 20 (66.7%) cases, IVC view was excellent; in 9 (30%) cases, was fair; and in 1 (3.3%) patient, we failed to visualize IVC. The guide-wire was identified in IVC in 12 (42.8%) patients, in another 9 (32.1%) patients guide-wire was visible in IVC after withdrawing and advancing it, and in RA in 6 (21.4%) patients. Catheters were successfully placed in 29 (96.7%) patients., Conclusions: Detection of the guide-wire confirms correct course of the procedure and increases the safety of catheter insertion without fluoroscopy., (© 2019 S. Karger AG, Basel.)
- Published
- 2020
- Full Text
- View/download PDF
50. Application of strain and other echocardiographic parameters in the evaluation of early and long-term clinical outcomes after cardiac surgery revascularization.
- Author
-
Gozdzik A, Letachowicz K, Grajek BB, Plonek T, Obremska M, Jasinski M, and Gozdzik W
- Subjects
- Aged, Cardiotonic Agents therapeutic use, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease mortality, Coronary Artery Disease physiopathology, Female, Humans, Male, Middle Aged, Postoperative Complications physiopathology, Postoperative Complications therapy, Predictive Value of Tests, Progression-Free Survival, Prospective Studies, Recovery of Function, Risk Factors, Time Factors, Coronary Artery Bypass adverse effects, Coronary Artery Bypass mortality, Coronary Artery Disease surgery, Echocardiography, Doppler, Pulsed, Postoperative Complications diagnostic imaging, Stroke Volume drug effects, Ventricular Function, Left drug effects
- Abstract
Background: Coronary artery bypass graft (CABG) surgery is an effective therapeutic strategy for coronary heart disease (CHD). Myocardial longitudinal strain echocardiography with 2D speckle tracking could obtain ventricular function with better accuracy and reliability than the left ventricular ejection fraction. The aim of the study was to assess changes in left ventricular function in patients before and after surgical revascularization for a 24-month period of observation, using echocardiography with speckle tracking strain imaging. We searched for echocardiographic predictors of poor early and long-term outcome after CABG., Methods: We enrolled 69 patients scheduled for elective coronary bypass grafting. Patients were divided into groups based on pre-operative systolic and diastolic parameters, depending on the GLS value and the E' Lat and E/E' value. The correlation between these parameters and early and long-term outcomes was analyzed., Results: Preoperative EF was preserved in 86, 95% (60) patients. Pre-operative reduced GLS was observed in 73.91% (51) of patients and severely reduced in 31.88% (22). In the first post-operative 6-month period, we observed a significant decrease in the GLS. The GLS was a predictor of early postoperative outcome for intubation time, the inotropes use and length of ICU stay. Diastolic dysfunction was a predictor of the greater inotrope requirements., Conclusions: Global longitudinal strain and diastolic dysfunction parameters are a good predictors of worse early outcome after CABG.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.